|
OMIM |
Link |
Information gain |
01 |
|
RA
|
[NCBI]
|
0.00159307
|
|
|
FSHMD1A
|
[NCBI]
|
0.00128739
|
|
|
electroencephalogram, low-voltage
|
[NCBI]
|
0.000999553
|
|
|
IDDM
|
[NCBI]
|
0.000948163
|
|
|
SLE
|
[NCBI]
|
0.000833414
|
|
|
polydactyly, postaxial, type a3
|
[NCBI]
|
0.000816782
|
|
|
DFNB35
|
[NCBI]
|
0.000816782
|
|
|
XGR
|
[NCBI]
|
0.000816782
|
|
|
acropectorovertebral dysplasia, f-form of
|
[NCBI]
|
0.000816782
|
|
|
DFNA52
|
[NCBI]
|
0.000816782
|
|
|
acropectoral syndrome
|
[NCBI]
|
0.000816782
|
|
|
STHAG5
|
[NCBI]
|
0.000816782
|
|
|
MRX78
|
[NCBI]
|
0.000816782
|
|
|
generalized epilepsy with febrile seizures plus, type 4
|
[NCBI]
|
0.000816782
|
|
|
hodgkin disease, y-linked pseudoautosomal
|
[NCBI]
|
0.000816782
|
|
|
deafness, congenital neurosensory, autosomal recessive 38
|
[NCBI]
|
0.000816782
|
|
|
myoclonic epilepsy, juvenile, 3
|
[NCBI]
|
0.000790653
|
|
|
stiff skin syndrome
|
[NCBI]
|
0.000699294
|
|
|
PSORS2
|
[NCBI]
|
0.000627572
|
|
|
FA
|
[NCBI]
|
0.000587266
|
|
|
MF4
|
[NCBI]
|
0.000554248
|
|
|
HCFP2
|
[NCBI]
|
0.000554248
|
|
|
CMD1K
|
[NCBI]
|
0.000554248
|
|
|
NYS4
|
[NCBI]
|
0.000554248
|
|
|
porokeratosis, disseminated superficial actinic, 2
|
[NCBI]
|
0.000554248
|
|
|
HHG
|
[NCBI]
|
0.000554248
|
|
|
SPAX1
|
[NCBI]
|
0.000554248
|
|
|
epilepsy, partial, with variable foci
|
[NCBI]
|
0.000554248
|
|
|
microcoria, congenital
|
[NCBI]
|
0.000554248
|
|
|
ichthyosis prematurity syndrome
|
[NCBI]
|
0.000554248
|
|
|
terminal osseous dysplasia and pigmentary defects
|
[NCBI]
|
0.000554248
|
|
|
ALS3
|
[NCBI]
|
0.000456827
|
|
|
PFHB2
|
[NCBI]
|
0.000456827
|
|
|
mental retardation with optic atrophy, deafness, and seizures
|
[NCBI]
|
0.000456827
|
|
|
xm system
|
[NCBI]
|
0.000456827
|
|
|
PSORS3
|
[NCBI]
|
0.000456827
|
|
|
dermal ridges-off-the-end
|
[NCBI]
|
0.000456827
|
|
|
GLC1M
|
[NCBI]
|
0.000456827
|
|
|
BLM
|
[NCBI]
|
0.000427452
|
|
|
CNA1
|
[NCBI]
|
0.000394503
|
|
|
DYT6
|
[NCBI]
|
0.000394503
|
|
|
RP6
|
[NCBI]
|
0.000394503
|
|
|
CCV
|
[NCBI]
|
0.000394503
|
|
|
MYP3
|
[NCBI]
|
0.000394503
|
|
|
PTOS1
|
[NCBI]
|
0.000394503
|
|
|
oligosynaptic infertility
|
[NCBI]
|
0.000394503
|
|
|
DFN4
|
[NCBI]
|
0.000394503
|
|
|
charcot-marie-tooth disease, dominant intermediate a
|
[NCBI]
|
0.000394503
|
|
|
DSMA3
|
[NCBI]
|
0.000394503
|
|
|
psoriasis susceptibility 8
|
[NCBI]
|
0.000394503
|
|
|
nasopharyngeal carcinoma 1
|
[NCBI]
|
0.000394503
|
|
|
RAG1
|
[NCBI]
|
0.000392871
|
|
|
OFC1
|
[NCBI]
|
0.000382247
|
|
|
splenic hypoplasia
|
[NCBI]
|
0.000348847
|
|
|
syndactyly, type i
|
[NCBI]
|
0.000348847
|
|
|
migraine, familial typical, susceptibility to, 2
|
[NCBI]
|
0.000348847
|
|
|
OPA4
|
[NCBI]
|
0.000348847
|
|
|
lethal congenital contracture syndrome 1
|
[NCBI]
|
0.000348847
|
|
|
malignant hyperthermia, susceptibility to, 2
|
[NCBI]
|
0.000348847
|
|
|
MRX3
|
[NCBI]
|
0.000348847
|
|
|
EFMR
|
[NCBI]
|
0.000348847
|
|
|
hereditary motor and sensory neuropathy, type iic
|
[NCBI]
|
0.000348847
|
|
|
recombinant chromosome 8 syndrome
|
[NCBI]
|
0.000333181
|
|
|
PFHB1B
|
[NCBI]
|
0.00031301
|
|
|
ASD1
|
[NCBI]
|
0.00028366
|
|
|
ECA1
|
[NCBI]
|
0.00028366
|
|
|
hodgkin disease, x-linked pseudoautosomal
|
[NCBI]
|
0.00028366
|
|
|
pseudohyperkalemia, familial, 1, due to red cell leak
|
[NCBI]
|
0.00028366
|
|
|
neuropathy, hereditary motor and sensory, russe type
|
[NCBI]
|
0.00028366
|
|
|
mental health wellness 1
|
[NCBI]
|
0.00028366
|
|
|
TAPVR1
|
[NCBI]
|
0.00028366
|
|
|
MCOP1
|
[NCBI]
|
0.00028366
|
|
|
severe combined immunodeficiency with sensitivity to ionizing radiation
|
[NCBI]
|
0.000281762
|
|
|
renal hamartomas, nephroblastomatosis, and fetal gigantism
|
[NCBI]
|
0.000258921
|
|
|
DFN2
|
[NCBI]
|
0.000258921
|
|
|
MTACR1
|
[NCBI]
|
0.000258921
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
0.000257393
|
|
|
digeorge syndrome/velocardiofacial syndrome spectrum of malformation 2
|
[NCBI]
|
0.00023763
|
|
|
CGF1
|
[NCBI]
|
0.00023763
|
|
|
CRC
|
[NCBI]
|
0.000233513
|
|
|
IGHG1
|
[NCBI]
|
0.000222829
|
|
|
RAG2
|
[NCBI]
|
0.00022058
|
|
|
AMCN
|
[NCBI]
|
0.000219015
|
|
|
MHS1
|
[NCBI]
|
0.000214725
|
|
|
EGF
|
[NCBI]
|
0.000214481
|
|
|
WRN
|
[NCBI]
|
0.000207497
|
|
|
chromosome 18 pericentric inversion
|
[NCBI]
|
0.000191504
|
|
|
ETL2
|
[NCBI]
|
0.000187808
|
|
|
telomere length, mean leukocyte
|
[NCBI]
|
0.000187808
|
|
|
short rib-polydactyly syndrome, type ii
|
[NCBI]
|
0.000187808
|
|
|
SCA1
|
[NCBI]
|
0.000184886
|
|
|
IBGC1
|
[NCBI]
|
0.000174534
|
|
|
CBBM
|
[NCBI]
|
0.000174534
|
|
|
MRD
|
[NCBI]
|
0.000174534
|
|
|
MCKD1
|
[NCBI]
|
0.000174534
|
|
|
spermatogenic failure, nonobstructive, y-linked
|
[NCBI]
|
0.000173453
|
|
|
FRDA
|
[NCBI]
|
0.000172009
|
|
|
CF
|
[NCBI]
|
0.000167267
|
|
|
TNF
|
[NCBI]
|
0.000164459
|
|
|
leber optic atrophy, susceptibility to
|
[NCBI]
|
0.00016249
|
|
|
AD
|
[NCBI]
|
0.000160702
|
|
|
DAR
|
[NCBI]
|
0.000157114
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
0.000155882
|
|
|
twinning, dizygotic
|
[NCBI]
|
0.000151501
|
|
|
glaucoma-related pigment dispersion syndrome
|
[NCBI]
|
0.000151501
|
|
|
alzheimer disease 2
|
[NCBI]
|
0.000148294
|
|
|
CMT2A1
|
[NCBI]
|
0.000148294
|
|
|
APRT
|
[NCBI]
|
0.000144404
|
|
|
VEGF
|
[NCBI]
|
0.000143993
|
|
|
RAD51
|
[NCBI]
|
0.000143435
|
|
|
IGAD1
|
[NCBI]
|
0.000141426
|
|
|
HLA-A
|
[NCBI]
|
0.000139769
|
|
|
ND
|
[NCBI]
|
0.000137378
|
|
|
RD
|
[NCBI]
|
0.000136294
|
|
|
epidermolysis bullosa simplex, ogna type
|
[NCBI]
|
0.000136294
|
|
|
AAVS1
|
[NCBI]
|
0.000136294
|
|
|
lig4 syndrome
|
[NCBI]
|
0.000136294
|
|
|
CMT1A
|
[NCBI]
|
0.000134506
|
|
|
GLC1A
|
[NCBI]
|
0.00013268
|
|
|
NGFB
|
[NCBI]
|
0.000132655
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
0.000131767
|
|
|
PGM1
|
[NCBI]
|
0.000128737
|
|
|
SMS
|
[NCBI]
|
0.000125835
|
|
|
HNA
|
[NCBI]
|
0.000123972
|
|
|
DHS
|
[NCBI]
|
0.000123578
|
|
|
SHFM3
|
[NCBI]
|
0.000123578
|
|
|
CDAN2
|
[NCBI]
|
0.000123578
|
|
|
RAD51AP1
|
[NCBI]
|
0.000122614
|
|
|
LIG4
|
[NCBI]
|
0.000121316
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
0.000120793
|
|
|
CNA2
|
[NCBI]
|
0.000115665
|
|
|
ragweed sensitivity
|
[NCBI]
|
0.000115665
|
|
|
SCZD3
|
[NCBI]
|
0.000115633
|
|
|
down syndrome
|
[NCBI]
|
0.000113147
|
|
|
PRL
|
[NCBI]
|
0.000113109
|
|
|
CSNB1A
|
[NCBI]
|
0.000112249
|
|
|
IGKC
|
[NCBI]
|
0.000108879
|
|
|
DSAP1
|
[NCBI]
|
0.000108445
|
|
|
rad54, s. cerevisiae, homolog of, b
|
[NCBI]
|
0.000107763
|
|
|
NPY
|
[NCBI]
|
0.000106677
|
|
|
PMP22
|
[NCBI]
|
0.000103763
|
|
|
FY
|
[NCBI]
|
0.000103239
|
|
|
FHM1
|
[NCBI]
|
0.000102654
|
|
|
AIH2
|
[NCBI]
|
0.000102387
|
|
|
SC
|
[NCBI]
|
0.000102387
|
|
|
AT
|
[NCBI]
|
0.000101594
|
|
|
TCRG
|
[NCBI]
|
0.000101193
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
0.000100508
|
|
|
BRCA2
|
[NCBI]
|
9.80344e-05
|
|
|
EBVS1
|
[NCBI]
|
9.7173e-05
|
|
|
AICDA
|
[NCBI]
|
9.67779e-05
|
|
|
RP3
|
[NCBI]
|
9.64673e-05
|
|
|
immunodeficiency with hyper-igm, type 4
|
[NCBI]
|
9.57355e-05
|
|
|
fragile site 10q23
|
[NCBI]
|
9.57355e-05
|
|
|
CMH2
|
[NCBI]
|
9.57355e-05
|
|
|
radiation sensitivity/chromosome instability syndrome, autosomal dominant
|
[NCBI]
|
9.57355e-05
|
|
|
fascial dystrophy, congenital
|
[NCBI]
|
9.57355e-05
|
|
|
TSN
|
[NCBI]
|
9.4277e-05
|
|
|
SPO11
|
[NCBI]
|
9.4277e-05
|
|
|
DA1
|
[NCBI]
|
9.26002e-05
|
|
|
DFNA2
|
[NCBI]
|
9.26002e-05
|
|
|
RAD51C
|
[NCBI]
|
9.1954e-05
|
|
|
RECQL3
|
[NCBI]
|
9.06477e-05
|
|
|
DCLRE1C
|
[NCBI]
|
8.97612e-05
|
|
|
diabetes mellitus, transient neonatal, 1
|
[NCBI]
|
8.89372e-05
|
|
|
DGI1
|
[NCBI]
|
8.85315e-05
|
|
|
XLP1
|
[NCBI]
|
8.75871e-05
|
|
|
myotonia congenita, autosomal recessive
|
[NCBI]
|
8.48696e-05
|
|
|
SEDT
|
[NCBI]
|
8.48696e-05
|
|
|
leiomyoma, hereditary multiple, of skin
|
[NCBI]
|
8.48696e-05
|
|
|
CLN5
|
[NCBI]
|
8.48696e-05
|
|
|
CMT2B
|
[NCBI]
|
8.48696e-05
|
|
|
OPD1
|
[NCBI]
|
8.1543e-05
|
|
|
KFSD
|
[NCBI]
|
8.1543e-05
|
|
|
SHEP1
|
[NCBI]
|
8.1543e-05
|
|
|
ACCPN
|
[NCBI]
|
8.1543e-05
|
|
|
PSORS1
|
[NCBI]
|
8.13012e-05
|
|
|
PTH
|
[NCBI]
|
8.06988e-05
|
|
|
DMD
|
[NCBI]
|
7.9156e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
7.86208e-05
|
|
|
TCRA
|
[NCBI]
|
7.85662e-05
|
|
|
MODY1
|
[NCBI]
|
7.84977e-05
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
7.75209e-05
|
|
|
GLO1
|
[NCBI]
|
7.70655e-05
|
|
|
RTS
|
[NCBI]
|
7.60575e-05
|
|
|
VMD
|
[NCBI]
|
7.60575e-05
|
|
|
KLK3
|
[NCBI]
|
7.58721e-05
|
|
|
BHC
|
[NCBI]
|
7.56916e-05
|
|
|
myotonia congenita, autosomal dominant
|
[NCBI]
|
7.56916e-05
|
|
|
XRN1
|
[NCBI]
|
7.51852e-05
|
|
|
CRH
|
[NCBI]
|
7.51621e-05
|
|
|
CFB
|
[NCBI]
|
7.353e-05
|
|
|
XRCC2
|
[NCBI]
|
7.31277e-05
|
|
|
CMDD
|
[NCBI]
|
7.30915e-05
|
|
|
lipomatosis, multiple
|
[NCBI]
|
7.30624e-05
|
|
|
HBFQTL2
|
[NCBI]
|
7.30624e-05
|
|
|
PKD1
|
[NCBI]
|
7.28069e-05
|
|
|
thyroid carcinoma, papillary
|
[NCBI]
|
7.23665e-05
|
|
|
PD
|
[NCBI]
|
7.22342e-05
|
|
|
RAD54L
|
[NCBI]
|
7.20029e-05
|
|
|
DMC1
|
[NCBI]
|
7.20029e-05
|
|
|
CMT1B
|
[NCBI]
|
7.11989e-05
|
|
|
C3
|
[NCBI]
|
7.09695e-05
|
|
|
ACHE
|
[NCBI]
|
7.07862e-05
|
|
|
EGFR
|
[NCBI]
|
7.05132e-05
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
6.98149e-05
|
|
|
HNPP
|
[NCBI]
|
6.89497e-05
|
|
|
immunoglobulin switch sequences
|
[NCBI]
|
6.81307e-05
|
|
|
hypoplastic left heart syndrome
|
[NCBI]
|
6.81307e-05
|
|
|
dermal ridges, nelson syndrome
|
[NCBI]
|
6.81307e-05
|
|
|
PLGL
|
[NCBI]
|
6.81307e-05
|
|
|
FIM1
|
[NCBI]
|
6.81307e-05
|
|
|
DFNA44
|
[NCBI]
|
6.81307e-05
|
|
|
HMN7B
|
[NCBI]
|
6.81307e-05
|
|
|
CBD
|
[NCBI]
|
6.80444e-05
|
|
|
CD99
|
[NCBI]
|
6.78806e-05
|
|
|
HD
|
[NCBI]
|
6.71959e-05
|
|
|
CCK
|
[NCBI]
|
6.64663e-05
|
|
|
ACP1
|
[NCBI]
|
6.63853e-05
|
|
|
EBN1
|
[NCBI]
|
6.62833e-05
|
|
|
CBP
|
[NCBI]
|
6.49552e-05
|
|
|
SHOX
|
[NCBI]
|
6.48213e-05
|
|
|
ABO
|
[NCBI]
|
6.48213e-05
|
|
|
RAD51L1
|
[NCBI]
|
6.36517e-05
|
|
|
PSMC3IP
|
[NCBI]
|
6.36517e-05
|
|
|
PGM3
|
[NCBI]
|
6.36235e-05
|
|
|
FUT2
|
[NCBI]
|
6.36235e-05
|
|
|
HSAN1
|
[NCBI]
|
6.23952e-05
|
|
|
BDNF
|
[NCBI]
|
6.18049e-05
|
|
|
SYCE2
|
[NCBI]
|
6.12985e-05
|
|
|
NF1
|
[NCBI]
|
6.09398e-05
|
|
|
RAD51L3
|
[NCBI]
|
6.06393e-05
|
|
|
VIP
|
[NCBI]
|
5.92276e-05
|
|
|
ATR
|
[NCBI]
|
5.89696e-05
|
|
|
MRE11A
|
[NCBI]
|
5.89696e-05
|
|
|
spastic ataxia
|
[NCBI]
|
5.78166e-05
|
|
|
moved to 310600
|
[NCBI]
|
5.78166e-05
|
|
|
mixed lymphocyte culture locus ii
|
[NCBI]
|
5.78166e-05
|
|
|
PLT1
|
[NCBI]
|
5.78166e-05
|
|
|
blood group--froese
|
[NCBI]
|
5.78166e-05
|
|
|
CHH
|
[NCBI]
|
5.65977e-05
|
|
|
EXO1
|
[NCBI]
|
5.58527e-05
|
|
|
SYCP3
|
[NCBI]
|
5.58527e-05
|
|
|
Ss
|
[NCBI]
|
5.58527e-05
|
|
|
NCAM1
|
[NCBI]
|
5.58527e-05
|
|
|
thiourea tasting
|
[NCBI]
|
5.57598e-05
|
|
|
PNKD1
|
[NCBI]
|
5.57598e-05
|
|
|
citrullinemia, classic
|
[NCBI]
|
5.57598e-05
|
|
|
gaucher disease, type iii
|
[NCBI]
|
5.57598e-05
|
|
|
CPX
|
[NCBI]
|
5.57598e-05
|
|
|
hepatocellular carcinoma
|
[NCBI]
|
5.4292e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
5.42055e-05
|
|
|
BCR
|
[NCBI]
|
5.40638e-05
|
|
|
RP
|
[NCBI]
|
5.24026e-05
|
|
|
RAD50
|
[NCBI]
|
5.21178e-05
|
|
|
PKD2
|
[NCBI]
|
5.13721e-05
|
|
|
immunodeficiency with hyper-igm, type 3
|
[NCBI]
|
5.11779e-05
|
|
|
fecundity gene, booroola, of sheep, homolog of
|
[NCBI]
|
5.11779e-05
|
|
|
HPE5
|
[NCBI]
|
5.11779e-05
|
|
|
CORD6
|
[NCBI]
|
5.11779e-05
|
|
|
EBN2
|
[NCBI]
|
5.11779e-05
|
|
|
simpson-golabi-behmel syndrome, type 2
|
[NCBI]
|
5.11779e-05
|
|
|
PTLS
|
[NCBI]
|
5.11779e-05
|
|
|
MRX30
|
[NCBI]
|
5.11779e-05
|
|
|
alpha-b crystallinopathy
|
[NCBI]
|
5.11779e-05
|
|
|
CMT1C
|
[NCBI]
|
5.11779e-05
|
|
|
G22P1
|
[NCBI]
|
5.05184e-05
|
|
|
HLA-B
|
[NCBI]
|
5.03802e-05
|
|
|
MN
|
[NCBI]
|
5.03802e-05
|
|
|
pyruvate decarboxylase deficiency
|
[NCBI]
|
5.02553e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
5.02553e-05
|
|
|
REC8L1
|
[NCBI]
|
4.99724e-05
|
|
|
IGHG4
|
[NCBI]
|
4.99724e-05
|
|
|
IGHJ
|
[NCBI]
|
4.99724e-05
|
|
|
LIG3
|
[NCBI]
|
4.99724e-05
|
|
|
GFAP
|
[NCBI]
|
4.93185e-05
|
|
|
PIM1
|
[NCBI]
|
4.90568e-05
|
|
|
NBS1
|
[NCBI]
|
4.90047e-05
|
|
|
PRKDC
|
[NCBI]
|
4.90047e-05
|
|
|
AS
|
[NCBI]
|
4.80318e-05
|
|
|
BCPM
|
[NCBI]
|
4.78274e-05
|
|
|
POLH
|
[NCBI]
|
4.77116e-05
|
|
|
LU
|
[NCBI]
|
4.77116e-05
|
|
|
LDHC
|
[NCBI]
|
4.64657e-05
|
|
|
RP7
|
[NCBI]
|
4.62848e-05
|
|
|
cd4/cd8 t-cell ratio
|
[NCBI]
|
4.62848e-05
|
|
|
RTADR
|
[NCBI]
|
4.62848e-05
|
|
|
RP15
|
[NCBI]
|
4.62848e-05
|
|
|
weyers acrofacial dysostosis
|
[NCBI]
|
4.62848e-05
|
|
|
MRX59
|
[NCBI]
|
4.62848e-05
|
|
|
white sponge nevus of cannon
|
[NCBI]
|
4.62848e-05
|
|
|
AH
|
[NCBI]
|
4.62848e-05
|
|
|
dentinogenesis imperfecta, shields type iii
|
[NCBI]
|
4.62848e-05
|
|
|
seizures, benign familial neonatal-infantile
|
[NCBI]
|
4.62848e-05
|
|
|
PDB1
|
[NCBI]
|
4.62848e-05
|
|
|
hairy ears
|
[NCBI]
|
4.62848e-05
|
|
|
RHCE
|
[NCBI]
|
4.59087e-05
|
|
|
LGMD2A
|
[NCBI]
|
4.55781e-05
|
|
|
AMY2A
|
[NCBI]
|
4.53059e-05
|
|
|
RYR1
|
[NCBI]
|
4.49401e-05
|
|
|
RMI1
|
[NCBI]
|
4.48723e-05
|
|
|
MND1
|
[NCBI]
|
4.48723e-05
|
|
|
GPI
|
[NCBI]
|
4.41902e-05
|
|
|
CADASIL
|
[NCBI]
|
4.34859e-05
|
|
|
CLL
|
[NCBI]
|
4.34859e-05
|
|
|
H2AFX
|
[NCBI]
|
4.32028e-05
|
|
|
HBZ
|
[NCBI]
|
4.32028e-05
|
|
|
C4A
|
[NCBI]
|
4.27075e-05
|
|
|
CMTX1
|
[NCBI]
|
4.24929e-05
|
|
|
DFNA5
|
[NCBI]
|
4.24197e-05
|
|
|
bartter syndrome, infantile, with sensorineural deafness
|
[NCBI]
|
4.24197e-05
|
|
|
pyruvate dehydrogenase e3-binding protein deficiency
|
[NCBI]
|
4.24197e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2b1
|
[NCBI]
|
4.24197e-05
|
|
|
CRS2
|
[NCBI]
|
4.24197e-05
|
|
|
UL
|
[NCBI]
|
4.24197e-05
|
|
|
hyperalphalipoproteinemia
|
[NCBI]
|
4.24197e-05
|
|
|
RP17
|
[NCBI]
|
4.24197e-05
|
|
|
ASS
|
[NCBI]
|
4.22562e-05
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
4.15326e-05
|
|
|
CDG1A
|
[NCBI]
|
4.15326e-05
|
|
|
PRKAR1B
|
[NCBI]
|
4.13819e-05
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
4.06033e-05
|
|
|
TNXB
|
[NCBI]
|
4.04763e-05
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
4.04218e-05
|
|
|
PDGFRA
|
[NCBI]
|
3.96593e-05
|
|
|
MEN1
|
[NCBI]
|
3.95549e-05
|
|
|
DMD
|
[NCBI]
|
3.95211e-05
|
|
|
MAFD2
|
[NCBI]
|
3.94681e-05
|
|
|
charcot-marie-tooth disease, dominant intermediate b
|
[NCBI]
|
3.92341e-05
|
|
|
cardiomyopathy, familial hypertrophic, with wolff-parkinson-white syndrome
|
[NCBI]
|
3.92341e-05
|
|
|
EJM1
|
[NCBI]
|
3.92341e-05
|
|
|
NEM2
|
[NCBI]
|
3.92341e-05
|
|
|
CO
|
[NCBI]
|
3.92341e-05
|
|
|
SHEP3
|
[NCBI]
|
3.92341e-05
|
|
|
CZP3
|
[NCBI]
|
3.92341e-05
|
|
|
mental health wellness 2
|
[NCBI]
|
3.92341e-05
|
|
|
POAG
|
[NCBI]
|
3.88311e-05
|
|
|
HOXD12
|
[NCBI]
|
3.87153e-05
|
|
|
switch-associated protein 70
|
[NCBI]
|
3.87153e-05
|
|
|
IFI6
|
[NCBI]
|
3.87153e-05
|
|
|
CHE2
|
[NCBI]
|
3.87153e-05
|
|
|
CDY1
|
[NCBI]
|
3.87153e-05
|
|
|
HOXD11
|
[NCBI]
|
3.87153e-05
|
|
|
GZMB
|
[NCBI]
|
3.74281e-05
|
|
|
PGP
|
[NCBI]
|
3.67477e-05
|
|
|
XRCC3
|
[NCBI]
|
3.65557e-05
|
|
|
SYCP1
|
[NCBI]
|
3.65557e-05
|
|
|
NCOA4
|
[NCBI]
|
3.65557e-05
|
|
|
SIL
|
[NCBI]
|
3.65557e-05
|
|
|
XRCC4
|
[NCBI]
|
3.65557e-05
|
|
|
HLA-F
|
[NCBI]
|
3.65557e-05
|
|
|
chromosome 17q21.31 microdeletion syndrome
|
[NCBI]
|
3.65557e-05
|
|
|
CKB
|
[NCBI]
|
3.65557e-05
|
|
|
EVR2
|
[NCBI]
|
3.65312e-05
|
|
|
PIL
|
[NCBI]
|
3.65312e-05
|
|
|
spinal muscular atrophy, proximal, adult, autosomal dominant
|
[NCBI]
|
3.65312e-05
|
|
|
ACHM3
|
[NCBI]
|
3.65312e-05
|
|
|
aceruloplasminemia
|
[NCBI]
|
3.65312e-05
|
|
|
EPD
|
[NCBI]
|
3.65312e-05
|
|
|
CMT4B1
|
[NCBI]
|
3.65312e-05
|
|
|
EDMD
|
[NCBI]
|
3.55935e-05
|
|
|
HMGA2
|
[NCBI]
|
3.4864e-05
|
|
|
SCIDX1
|
[NCBI]
|
3.4841e-05
|
|
|
BRCA1
|
[NCBI]
|
3.48265e-05
|
|
|
GSTA2
|
[NCBI]
|
3.47411e-05
|
|
|
KIF1B
|
[NCBI]
|
3.47411e-05
|
|
|
AKAP9
|
[NCBI]
|
3.47411e-05
|
|
|
CCDC6
|
[NCBI]
|
3.47411e-05
|
|
|
AR
|
[NCBI]
|
3.42113e-05
|
|
|
arbitrary restriction polymorphism 1
|
[NCBI]
|
3.41894e-05
|
|
|
RMS1
|
[NCBI]
|
3.41894e-05
|
|
|
IHCM
|
[NCBI]
|
3.41894e-05
|
|
|
SPG10
|
[NCBI]
|
3.41894e-05
|
|
|
LRS1
|
[NCBI]
|
3.41894e-05
|
|
|
RHN
|
[NCBI]
|
3.41894e-05
|
|
|
reifenstein syndrome
|
[NCBI]
|
3.41894e-05
|
|
|
CMT2D
|
[NCBI]
|
3.41894e-05
|
|
|
HES
|
[NCBI]
|
3.41894e-05
|
|
|
LWD
|
[NCBI]
|
3.41092e-05
|
|
|
PCOS1
|
[NCBI]
|
3.40773e-05
|
|
|
FTD
|
[NCBI]
|
3.32724e-05
|
|
|
AK1
|
[NCBI]
|
3.31797e-05
|
|
|
TOP3A
|
[NCBI]
|
3.31772e-05
|
|
|
GRIK1
|
[NCBI]
|
3.31772e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
3.28195e-05
|
|
|
HEMB
|
[NCBI]
|
3.24491e-05
|
|
|
NETH
|
[NCBI]
|
3.21277e-05
|
|
|
CZP1
|
[NCBI]
|
3.21277e-05
|
|
|
hyperostosis corticalis generalisata
|
[NCBI]
|
3.21277e-05
|
|
|
PKD3
|
[NCBI]
|
3.21277e-05
|
|
|
erythermalgia, primary
|
[NCBI]
|
3.21277e-05
|
|
|
CMT4D
|
[NCBI]
|
3.21277e-05
|
|
|
liddle syndrome
|
[NCBI]
|
3.21277e-05
|
|
|
situs inversus viscerum
|
[NCBI]
|
3.21277e-05
|
|
|
PBT
|
[NCBI]
|
3.21277e-05
|
|
|
CSNB2A
|
[NCBI]
|
3.21277e-05
|
|
|
NYS1
|
[NCBI]
|
3.21277e-05
|
|
|
ZIC2
|
[NCBI]
|
3.18037e-05
|
|
|
IGHE
|
[NCBI]
|
3.18037e-05
|
|
|
RAC2
|
[NCBI]
|
3.18037e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
3.16584e-05
|
|
|
LDLR
|
[NCBI]
|
3.1226e-05
|
|
|
CYP2A6
|
[NCBI]
|
3.11826e-05
|
|
|
PARP1
|
[NCBI]
|
3.1023e-05
|
|
|
CLS
|
[NCBI]
|
3.07312e-05
|
|
|
immunoglobulin: d (diversity) region of heavy chain
|
[NCBI]
|
3.06471e-05
|
|
|
x123 gene
|
[NCBI]
|
3.06471e-05
|
|
|
ERVT1
|
[NCBI]
|
3.06471e-05
|
|
|
ERVT3
|
[NCBI]
|
3.06471e-05
|
|
|
ERVT5
|
[NCBI]
|
3.06471e-05
|
|
|
AMY1B
|
[NCBI]
|
3.06471e-05
|
|
|
ERVT2
|
[NCBI]
|
3.06471e-05
|
|
|
FAM9C
|
[NCBI]
|
3.06471e-05
|
|
|
xk-related protein on y chromosome
|
[NCBI]
|
3.06471e-05
|
|
|
CCNB2
|
[NCBI]
|
3.06471e-05
|
|
|
ERVT4
|
[NCBI]
|
3.06471e-05
|
|
|
KIR3DP1
|
[NCBI]
|
3.06471e-05
|
|
|
EIF1AY
|
[NCBI]
|
3.06471e-05
|
|
|
FAM9A
|
[NCBI]
|
3.06471e-05
|
|
|
SYCE1
|
[NCBI]
|
3.06471e-05
|
|
|
PSMD7
|
[NCBI]
|
3.06471e-05
|
|
|
FAM9B
|
[NCBI]
|
3.06471e-05
|
|
|
IGKDEL
|
[NCBI]
|
3.06471e-05
|
|
|
XGR
|
[NCBI]
|
3.06471e-05
|
|
|
PEPC
|
[NCBI]
|
3.05799e-05
|
|
|
PRB1
|
[NCBI]
|
3.05799e-05
|
|
|
IRID1
|
[NCBI]
|
3.029e-05
|
|
|
PFHB1A
|
[NCBI]
|
3.029e-05
|
|
|
BDA1
|
[NCBI]
|
3.029e-05
|
|
|
cirrhosis, familial
|
[NCBI]
|
3.029e-05
|
|
|
SCZD2
|
[NCBI]
|
3.029e-05
|
|
|
coloboma, ocular
|
[NCBI]
|
3.029e-05
|
|
|
CMT2A2
|
[NCBI]
|
3.029e-05
|
|
|
DFNA12
|
[NCBI]
|
3.029e-05
|
|
|
FANCA
|
[NCBI]
|
3.02728e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
3.01561e-05
|
|
|
ARPKD
|
[NCBI]
|
3.01065e-05
|
|
|
RS1
|
[NCBI]
|
2.98374e-05
|
|
|
RECQL2
|
[NCBI]
|
2.98374e-05
|
|
|
XRCC5
|
[NCBI]
|
2.94768e-05
|
|
|
SUZ12
|
[NCBI]
|
2.94768e-05
|
|
|
ASPM
|
[NCBI]
|
2.94768e-05
|
|
|
FUT3
|
[NCBI]
|
2.94768e-05
|
|
|
PEE1
|
[NCBI]
|
2.92634e-05
|
|
|
RHO
|
[NCBI]
|
2.90583e-05
|
|
|
CHAT
|
[NCBI]
|
2.90013e-05
|
|
|
VDR
|
[NCBI]
|
2.89455e-05
|
|
|
CHM
|
[NCBI]
|
2.89028e-05
|
|
|
APOE
|
[NCBI]
|
2.88185e-05
|
|
|
DFNA6
|
[NCBI]
|
2.86352e-05
|
|
|
hyperlipoproteinemia, type ii
|
[NCBI]
|
2.86352e-05
|
|
|
tight skin contracture syndrome, lethal
|
[NCBI]
|
2.86352e-05
|
|
|
gaucher disease, type ii
|
[NCBI]
|
2.86352e-05
|
|
|
HRPT2
|
[NCBI]
|
2.86352e-05
|
|
|
DA2B
|
[NCBI]
|
2.86352e-05
|
|
|
sertoli cell-only syndrome, y-linked
|
[NCBI]
|
2.86352e-05
|
|
|
PPD2
|
[NCBI]
|
2.86352e-05
|
|
|
SNDI
|
[NCBI]
|
2.86352e-05
|
|
|
apolipoprotein c-ii deficiency
|
[NCBI]
|
2.86352e-05
|
|
|
SIRT1
|
[NCBI]
|
2.8601e-05
|
|
|
SEPT9
|
[NCBI]
|
2.84734e-05
|
|
|
NCOA6
|
[NCBI]
|
2.84734e-05
|
|
|
TH
|
[NCBI]
|
2.8388e-05
|
|
|
BTK
|
[NCBI]
|
2.77581e-05
|
|
|
FEN1
|
[NCBI]
|
2.75535e-05
|
|
|
IKBKAP
|
[NCBI]
|
2.75535e-05
|
|
|
MCF2
|
[NCBI]
|
2.75535e-05
|
|
|
EN2
|
[NCBI]
|
2.75535e-05
|
|
|
CDK5R1
|
[NCBI]
|
2.75535e-05
|
|
|
ABCB4
|
[NCBI]
|
2.75535e-05
|
|
|
SOX9
|
[NCBI]
|
2.74583e-05
|
|
|
denys-drash syndrome
|
[NCBI]
|
2.71328e-05
|
|
|
DSMA1
|
[NCBI]
|
2.71328e-05
|
|
|
wolff-parkinson-white syndrome
|
[NCBI]
|
2.71328e-05
|
|
|
adrenal hyperplasia, congenital, due to steroid 11-beta-hydroxylase deficiency
|
[NCBI]
|
2.71328e-05
|
|
|
RENS1
|
[NCBI]
|
2.71328e-05
|
|
|
FTNS
|
[NCBI]
|
2.71328e-05
|
|
|
mulibrey nanism
|
[NCBI]
|
2.71328e-05
|
|
|
amelogenesis imperfecta, hypoplastic/hypomaturation, x-linked 1
|
[NCBI]
|
2.71328e-05
|
|
|
parkinson disease, mitochondrial
|
[NCBI]
|
2.71328e-05
|
|
|
HP
|
[NCBI]
|
2.69211e-05
|
|
|
VLDLR
|
[NCBI]
|
2.67423e-05
|
|
|
DNAH11
|
[NCBI]
|
2.67046e-05
|
|
|
PRH1
|
[NCBI]
|
2.67046e-05
|
|
|
NEFH
|
[NCBI]
|
2.67046e-05
|
|
|
SCN2A
|
[NCBI]
|
2.67046e-05
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
2.63969e-05
|
|
|
AFP
|
[NCBI]
|
2.61714e-05
|
|
|
IGLC1
|
[NCBI]
|
2.59169e-05
|
|
|
TAP1
|
[NCBI]
|
2.59169e-05
|
|
|
MOS
|
[NCBI]
|
2.59169e-05
|
|
|
EPO
|
[NCBI]
|
2.58959e-05
|
|
|
LQT3
|
[NCBI]
|
2.57592e-05
|
|
|
CORDX1
|
[NCBI]
|
2.57592e-05
|
|
|
BHD
|
[NCBI]
|
2.57592e-05
|
|
|
EA1
|
[NCBI]
|
2.57592e-05
|
|
|
SPD1
|
[NCBI]
|
2.57592e-05
|
|
|
JLNS1
|
[NCBI]
|
2.57592e-05
|
|
|
cerebrotendinous xanthomatosis
|
[NCBI]
|
2.57592e-05
|
|
|
FRA16A
|
[NCBI]
|
2.57592e-05
|
|
|
WGN1
|
[NCBI]
|
2.57592e-05
|
|
|
OPD2
|
[NCBI]
|
2.57592e-05
|
|
|
CFEOM1
|
[NCBI]
|
2.57592e-05
|
|
|
MLL
|
[NCBI]
|
2.57296e-05
|
|
|
RP2
|
[NCBI]
|
2.5407e-05
|
|
|
JARID2
|
[NCBI]
|
2.51824e-05
|
|
|
HLA-DPA1
|
[NCBI]
|
2.51824e-05
|
|
|
BEST1
|
[NCBI]
|
2.51824e-05
|
|
|
NCF1
|
[NCBI]
|
2.51824e-05
|
|
|
klippel-trenaunay-weber syndrome
|
[NCBI]
|
2.49679e-05
|
|
|
F13A1
|
[NCBI]
|
2.47826e-05
|
|
|
gaucher disease, type i
|
[NCBI]
|
2.46203e-05
|
|
|
ADLTE
|
[NCBI]
|
2.4496e-05
|
|
|
nondisjunction
|
[NCBI]
|
2.4496e-05
|
|
|
omenn syndrome
|
[NCBI]
|
2.4496e-05
|
|
|
PPCD1
|
[NCBI]
|
2.4496e-05
|
|
|
SOST
|
[NCBI]
|
2.4496e-05
|
|
|
CMPK1
|
[NCBI]
|
2.44947e-05
|
|
|
EN1
|
[NCBI]
|
2.44947e-05
|
|
|
FXN
|
[NCBI]
|
2.44803e-05
|
|
|
hemophilia a
|
[NCBI]
|
2.41956e-05
|
|
|
MEN2A
|
[NCBI]
|
2.41376e-05
|
|
|
apc gene
|
[NCBI]
|
2.40571e-05
|
|
|
SRC
|
[NCBI]
|
2.38545e-05
|
|
|
GDI1
|
[NCBI]
|
2.38483e-05
|
|
|
CD40
|
[NCBI]
|
2.38483e-05
|
|
|
RAF1
|
[NCBI]
|
2.38483e-05
|
|
|
JK
|
[NCBI]
|
2.38483e-05
|
|
|
PLP1
|
[NCBI]
|
2.36098e-05
|
|
|
exostoses, multiple, type ii
|
[NCBI]
|
2.33284e-05
|
|
|
helicobacter pylori infection, susceptibility to
|
[NCBI]
|
2.33284e-05
|
|
|
lecithin:cholesterol acyltransferase deficiency
|
[NCBI]
|
2.33284e-05
|
|
|
seckel syndrome 1
|
[NCBI]
|
2.33284e-05
|
|
|
VED
|
[NCBI]
|
2.33284e-05
|
|
|
ehlers-danlos syndrome, type vi
|
[NCBI]
|
2.33284e-05
|
|
|
infantile sialic acid storage disorder
|
[NCBI]
|
2.33284e-05
|
|
|
TERF2
|
[NCBI]
|
2.32389e-05
|
|
|
NEU1
|
[NCBI]
|
2.26625e-05
|
|
|
PGD
|
[NCBI]
|
2.26625e-05
|
|
|
BPY2
|
[NCBI]
|
2.24341e-05
|
|
|
KIF2
|
[NCBI]
|
2.24341e-05
|
|
|
OTOA
|
[NCBI]
|
2.24341e-05
|
|
|
STAG1
|
[NCBI]
|
2.24341e-05
|
|
|
TREX2
|
[NCBI]
|
2.24341e-05
|
|
|
CDY2
|
[NCBI]
|
2.24341e-05
|
|
|
minisatellite 33.6
|
[NCBI]
|
2.24341e-05
|
|
|
TM7SF2
|
[NCBI]
|
2.24341e-05
|
|
|
C6ORF27
|
[NCBI]
|
2.24341e-05
|
|
|
minisatellite 33.15
|
[NCBI]
|
2.24341e-05
|
|
|
GSDML
|
[NCBI]
|
2.24341e-05
|
|
|
CD37
|
[NCBI]
|
2.24341e-05
|
|
|
FBXL16
|
[NCBI]
|
2.24341e-05
|
|
|
RAD52
|
[NCBI]
|
2.24341e-05
|
|
|
ZNF79
|
[NCBI]
|
2.24341e-05
|
|
|
PIGN
|
[NCBI]
|
2.24341e-05
|
|
|
NEURL
|
[NCBI]
|
2.24341e-05
|
|
|
kua gene
|
[NCBI]
|
2.24341e-05
|
|
|
FRV1
|
[NCBI]
|
2.24341e-05
|
|
|
STAG2
|
[NCBI]
|
2.24341e-05
|
|
|
NGFG
|
[NCBI]
|
2.24341e-05
|
|
|
ZBTB34
|
[NCBI]
|
2.24341e-05
|
|
|
atr-interacting protein
|
[NCBI]
|
2.24341e-05
|
|
|
TMSB4Y
|
[NCBI]
|
2.24341e-05
|
|
|
yeast factor
|
[NCBI]
|
2.24341e-05
|
|
|
VCY
|
[NCBI]
|
2.24341e-05
|
|
|
RECQL5
|
[NCBI]
|
2.24341e-05
|
|
|
OVOL1
|
[NCBI]
|
2.24341e-05
|
|
|
MKKS
|
[NCBI]
|
2.22445e-05
|
|
|
OPTB3
|
[NCBI]
|
2.22445e-05
|
|
|
DYX2
|
[NCBI]
|
2.22445e-05
|
|
|
DYT3
|
[NCBI]
|
2.22445e-05
|
|
|
DHRD
|
[NCBI]
|
2.22445e-05
|
|
|
NPHS1
|
[NCBI]
|
2.22445e-05
|
|
|
blood group, p system
|
[NCBI]
|
2.22445e-05
|
|
|
neuropathy, congenital hypomyelinating
|
[NCBI]
|
2.22445e-05
|
|
|
dopamine beta-hydroxylase deficiency, congenital
|
[NCBI]
|
2.22445e-05
|
|
|
SPG2
|
[NCBI]
|
2.22445e-05
|
|
|
SCZD1
|
[NCBI]
|
2.22445e-05
|
|
|
HPRT1
|
[NCBI]
|
2.17826e-05
|
|
|
HOXD13
|
[NCBI]
|
2.15967e-05
|
|
|
PLOD1
|
[NCBI]
|
2.15967e-05
|
|
|
CEACAM5
|
[NCBI]
|
2.14871e-05
|
|
|
BCL2
|
[NCBI]
|
2.12816e-05
|
|
|
camurati-engelmann disease
|
[NCBI]
|
2.12344e-05
|
|
|
properdin deficiency, x-linked
|
[NCBI]
|
2.12344e-05
|
|
|
EA2
|
[NCBI]
|
2.12344e-05
|
|
|
SCN1
|
[NCBI]
|
2.12344e-05
|
|
|
CCND1
|
[NCBI]
|
2.09914e-05
|
|
|
HGF
|
[NCBI]
|
2.08541e-05
|
|
|
EMD
|
[NCBI]
|
2.06297e-05
|
|
|
NPHP1
|
[NCBI]
|
2.02899e-05
|
|
|
PWS
|
[NCBI]
|
2.02542e-05
|
|
|
LPL
|
[NCBI]
|
1.99717e-05
|
|
|
RET
|
[NCBI]
|
1.99461e-05
|
|
|
MODY
|
[NCBI]
|
1.97876e-05
|
|
|
DA2A
|
[NCBI]
|
1.9404e-05
|
|
|
autonomic control, congenital failure of
|
[NCBI]
|
1.9404e-05
|
|
|
MSS
|
[NCBI]
|
1.9404e-05
|
|
|
MEN2B
|
[NCBI]
|
1.9404e-05
|
|
|
PAFAH1B3
|
[NCBI]
|
1.93556e-05
|
|
|
C20ORF41
|
[NCBI]
|
1.93556e-05
|
|
|
CKS2
|
[NCBI]
|
1.93556e-05
|
|
|
PRKY
|
[NCBI]
|
1.93556e-05
|
|
|
SCN3A
|
[NCBI]
|
1.93556e-05
|
|
|
IGLP1
|
[NCBI]
|
1.93556e-05
|
|
|
CYP2F1
|
[NCBI]
|
1.93556e-05
|
|
|
IHG
|
[NCBI]
|
1.93556e-05
|
|
|
CHK
|
[NCBI]
|
1.93556e-05
|
|
|
nnx3 protein
|
[NCBI]
|
1.93556e-05
|
|
|
C11ORF5
|
[NCBI]
|
1.93556e-05
|
|
|
fshd gene 2
|
[NCBI]
|
1.93556e-05
|
|
|
CCL3L2
|
[NCBI]
|
1.93556e-05
|
|
|
KY
|
[NCBI]
|
1.93556e-05
|
|
|
KCNJ10
|
[NCBI]
|
1.93556e-05
|
|
|
INA
|
[NCBI]
|
1.93556e-05
|
|
|
major histocompatibility complex, class i, gene p5-1
|
[NCBI]
|
1.93556e-05
|
|
|
GPR65
|
[NCBI]
|
1.93556e-05
|
|
|
UCK2
|
[NCBI]
|
1.93556e-05
|
|
|
PRKX
|
[NCBI]
|
1.93556e-05
|
|
|
ASMTL
|
[NCBI]
|
1.93556e-05
|
|
|
MOBP
|
[NCBI]
|
1.93556e-05
|
|
|
THEG
|
[NCBI]
|
1.93556e-05
|
|
|
PRY2
|
[NCBI]
|
1.93556e-05
|
|
|
HSF2
|
[NCBI]
|
1.93556e-05
|
|
|
DDX3
|
[NCBI]
|
1.93556e-05
|
|
|
ATP6V0A4
|
[NCBI]
|
1.93556e-05
|
|
|
SMC1B
|
[NCBI]
|
1.93556e-05
|
|
|
ESCO1
|
[NCBI]
|
1.93556e-05
|
|
|
ELOVL3
|
[NCBI]
|
1.93556e-05
|
|
|
GSTM5
|
[NCBI]
|
1.93556e-05
|
|
|
C14ORF58
|
[NCBI]
|
1.93556e-05
|
|
|
CHM
|
[NCBI]
|
1.93311e-05
|
|
|
TNFSF6
|
[NCBI]
|
1.92583e-05
|
|
|
SMA1
|
[NCBI]
|
1.90746e-05
|
|
|
TYMS
|
[NCBI]
|
1.89361e-05
|
|
|
MUT
|
[NCBI]
|
1.89327e-05
|
|
|
HBG1
|
[NCBI]
|
1.86927e-05
|
|
|
NHS
|
[NCBI]
|
1.85709e-05
|
|
|
CDPX1
|
[NCBI]
|
1.85709e-05
|
|
|
osteogenesis imperfecta, type iii
|
[NCBI]
|
1.85709e-05
|
|
|
C1NH
|
[NCBI]
|
1.85495e-05
|
|
|
TCRB
|
[NCBI]
|
1.85495e-05
|
|
|
CAT
|
[NCBI]
|
1.81877e-05
|
|
|
complement component 6 deficiency
|
[NCBI]
|
1.78247e-05
|
|
|
CHAC
|
[NCBI]
|
1.77856e-05
|
|
|
sialuria, finnish type
|
[NCBI]
|
1.77856e-05
|
|
|
PPH1
|
[NCBI]
|
1.77856e-05
|
|
|
mucolipidosis iv
|
[NCBI]
|
1.77856e-05
|
|
|
epidermolysis bullosa with pyloric atresia
|
[NCBI]
|
1.77856e-05
|
|
|
deafness, conductive, with stapes fixation
|
[NCBI]
|
1.77856e-05
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
1.74813e-05
|
|
|
MYC
|
[NCBI]
|
1.73907e-05
|
|
|
MINPP1
|
[NCBI]
|
1.73685e-05
|
|
|
ITGA7
|
[NCBI]
|
1.73685e-05
|
|
|
ANGPTL2
|
[NCBI]
|
1.73685e-05
|
|
|
IPP
|
[NCBI]
|
1.73685e-05
|
|
|
neutrophil-specific antigen 1
|
[NCBI]
|
1.73685e-05
|
|
|
AOC2
|
[NCBI]
|
1.73685e-05
|
|
|
PRY
|
[NCBI]
|
1.73685e-05
|
|
|
CRTL1
|
[NCBI]
|
1.73685e-05
|
|
|
TAL2
|
[NCBI]
|
1.73685e-05
|
|
|
LIPH
|
[NCBI]
|
1.73685e-05
|
|
|
MLLT3
|
[NCBI]
|
1.73685e-05
|
|
|
RPA3
|
[NCBI]
|
1.73685e-05
|
|
|
deleted in split-hand/split-foot 1 region
|
[NCBI]
|
1.73685e-05
|
|
|
RPL27
|
[NCBI]
|
1.73685e-05
|
|
|
EGR4
|
[NCBI]
|
1.73685e-05
|
|
|
USP6
|
[NCBI]
|
1.73685e-05
|
|
|
GPRK5
|
[NCBI]
|
1.73685e-05
|
|
|
UBE2V1
|
[NCBI]
|
1.73685e-05
|
|
|
SLC5A3
|
[NCBI]
|
1.73685e-05
|
|
|
FAT
|
[NCBI]
|
1.73685e-05
|
|
|
EFHC1
|
[NCBI]
|
1.73685e-05
|
|
|
NUDT1
|
[NCBI]
|
1.73685e-05
|
|
|
DYNLT1
|
[NCBI]
|
1.73685e-05
|
|
|
LY9
|
[NCBI]
|
1.73685e-05
|
|
|
SOX21
|
[NCBI]
|
1.73685e-05
|
|
|
SCARB2
|
[NCBI]
|
1.73685e-05
|
|
|
DPP6
|
[NCBI]
|
1.73685e-05
|
|
|
SLC12A6
|
[NCBI]
|
1.73685e-05
|
|
|
RAD18
|
[NCBI]
|
1.73685e-05
|
|
|
NEF3
|
[NCBI]
|
1.73685e-05
|
|
|
CANX
|
[NCBI]
|
1.73685e-05
|
|
|
PAXIP1
|
[NCBI]
|
1.73685e-05
|
|
|
MIRN1-2
|
[NCBI]
|
1.73685e-05
|
|
|
CLK2
|
[NCBI]
|
1.73685e-05
|
|
|
CCDC50
|
[NCBI]
|
1.73685e-05
|
|
|
GPNMB
|
[NCBI]
|
1.73685e-05
|
|
|
RPL12
|
[NCBI]
|
1.73685e-05
|
|
|
GZMH
|
[NCBI]
|
1.73685e-05
|
|
|
SPANXB1
|
[NCBI]
|
1.73685e-05
|
|
|
MUS81
|
[NCBI]
|
1.73685e-05
|
|
|
RNU3
|
[NCBI]
|
1.73685e-05
|
|
|
SOX18
|
[NCBI]
|
1.73685e-05
|
|
|
FRG1
|
[NCBI]
|
1.73685e-05
|
|
|
NEDD4L
|
[NCBI]
|
1.73685e-05
|
|
|
LAF4
|
[NCBI]
|
1.73685e-05
|
|
|
GABRB1
|
[NCBI]
|
1.73685e-05
|
|
|
EIF1AX
|
[NCBI]
|
1.73685e-05
|
|
|
RAC1
|
[NCBI]
|
1.71496e-05
|
|
|
EKV
|
[NCBI]
|
1.70437e-05
|
|
|
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency
|
[NCBI]
|
1.70437e-05
|
|
|
USH2A
|
[NCBI]
|
1.70437e-05
|
|
|
niemann-pick disease, type a
|
[NCBI]
|
1.70437e-05
|
|
|
wilson disease
|
[NCBI]
|
1.69641e-05
|
|
|
CLCN1
|
[NCBI]
|
1.68288e-05
|
|
|
CYBB
|
[NCBI]
|
1.68288e-05
|
|
|
RB1
|
[NCBI]
|
1.66949e-05
|
|
|
MTTK
|
[NCBI]
|
1.65183e-05
|
|
|
GBA
|
[NCBI]
|
1.63733e-05
|
|
|
HOKPP
|
[NCBI]
|
1.63415e-05
|
|
|
FHIT
|
[NCBI]
|
1.62176e-05
|
|
|
TYRP1
|
[NCBI]
|
1.62176e-05
|
|
|
HBB
|
[NCBI]
|
1.59785e-05
|
|
|
NDP
|
[NCBI]
|
1.5926e-05
|
|
|
NR6A1
|
[NCBI]
|
1.5926e-05
|
|
|
MYO7A
|
[NCBI]
|
1.5926e-05
|
|
|
PDGFB
|
[NCBI]
|
1.5926e-05
|
|
|
GATA1
|
[NCBI]
|
1.5926e-05
|
|
|
GBP1
|
[NCBI]
|
1.58998e-05
|
|
|
CDR1
|
[NCBI]
|
1.58998e-05
|
|
|
CEBPD
|
[NCBI]
|
1.58998e-05
|
|
|
PALB2
|
[NCBI]
|
1.58998e-05
|
|
|
MAP3K13
|
[NCBI]
|
1.58998e-05
|
|
|
NBL1
|
[NCBI]
|
1.58998e-05
|
|
|
LECT1
|
[NCBI]
|
1.58998e-05
|
|
|
GYPE
|
[NCBI]
|
1.58998e-05
|
|
|
SFRS2
|
[NCBI]
|
1.58998e-05
|
|
|
NBEA
|
[NCBI]
|
1.58998e-05
|
|
|
LTBP3
|
[NCBI]
|
1.58998e-05
|
|
|
DPAGT1
|
[NCBI]
|
1.58998e-05
|
|
|
STRC
|
[NCBI]
|
1.58998e-05
|
|
|
ENDOG
|
[NCBI]
|
1.58998e-05
|
|
|
TOP3B
|
[NCBI]
|
1.58998e-05
|
|
|
GDF6
|
[NCBI]
|
1.58998e-05
|
|
|
ACTR1A
|
[NCBI]
|
1.58998e-05
|
|
|
EVC
|
[NCBI]
|
1.58998e-05
|
|
|
SENP2
|
[NCBI]
|
1.58998e-05
|
|
|
PRDM2
|
[NCBI]
|
1.58998e-05
|
|
|
rapamycin-insensitive companion of mtor
|
[NCBI]
|
1.58998e-05
|
|
|
MX1
|
[NCBI]
|
1.58998e-05
|
|
|
MSH4
|
[NCBI]
|
1.58998e-05
|
|
|
TJP2
|
[NCBI]
|
1.58998e-05
|
|
|
homeobox protein, pepp subfamily, 2
|
[NCBI]
|
1.58998e-05
|
|
|
KLF15
|
[NCBI]
|
1.58998e-05
|
|
|
FBP1
|
[NCBI]
|
1.58998e-05
|
|
|
feline leukemia virus subgroup c receptor
|
[NCBI]
|
1.58998e-05
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
1.57393e-05
|
|
|
MRXHF1
|
[NCBI]
|
1.56756e-05
|
|
|
PDB
|
[NCBI]
|
1.56756e-05
|
|
|
OCRL
|
[NCBI]
|
1.56756e-05
|
|
|
central core disease of muscle
|
[NCBI]
|
1.56756e-05
|
|
|
AHR
|
[NCBI]
|
1.56268e-05
|
|
|
OPTN
|
[NCBI]
|
1.53685e-05
|
|
|
GJA1
|
[NCBI]
|
1.52596e-05
|
|
|
ALD
|
[NCBI]
|
1.51806e-05
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
1.51017e-05
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
1.50431e-05
|
|
|
LCA1
|
[NCBI]
|
1.50431e-05
|
|
|
MYH11
|
[NCBI]
|
1.48424e-05
|
|
|
ovary-, testis-, and epididymis-expressed gene
|
[NCBI]
|
1.47364e-05
|
|
|
GGTA1
|
[NCBI]
|
1.47364e-05
|
|
|
ANXA4
|
[NCBI]
|
1.47364e-05
|
|
|
IGHD
|
[NCBI]
|
1.47364e-05
|
|
|
ribonucleic acid, ribosomal, 5s
|
[NCBI]
|
1.47364e-05
|
|
|
UBE2N
|
[NCBI]
|
1.47364e-05
|
|
|
GABRA2
|
[NCBI]
|
1.47364e-05
|
|
|
SGOL1
|
[NCBI]
|
1.47364e-05
|
|
|
RPA2
|
[NCBI]
|
1.47364e-05
|
|
|
C8G
|
[NCBI]
|
1.47364e-05
|
|
|
TALDO1
|
[NCBI]
|
1.47364e-05
|
|
|
COTL1
|
[NCBI]
|
1.47364e-05
|
|
|
SLC7A1
|
[NCBI]
|
1.47364e-05
|
|
|
SLC9A3
|
[NCBI]
|
1.47364e-05
|
|
|
HELLS
|
[NCBI]
|
1.47364e-05
|
|
|
NTF5
|
[NCBI]
|
1.47364e-05
|
|
|
MLLT2
|
[NCBI]
|
1.47364e-05
|
|
|
KPNA1
|
[NCBI]
|
1.47364e-05
|
|
|
MLH3
|
[NCBI]
|
1.47364e-05
|
|
|
MIC2Y
|
[NCBI]
|
1.47364e-05
|
|
|
GABRA4
|
[NCBI]
|
1.47364e-05
|
|
|
MSH5
|
[NCBI]
|
1.47364e-05
|
|
|
P2RY1
|
[NCBI]
|
1.47364e-05
|
|
|
CRMP1
|
[NCBI]
|
1.47364e-05
|
|
|
PRKAR2B
|
[NCBI]
|
1.47364e-05
|
|
|
MAP3K2
|
[NCBI]
|
1.47364e-05
|
|
|
LW
|
[NCBI]
|
1.47364e-05
|
|
|
IL4
|
[NCBI]
|
1.47054e-05
|
|
|
HBFQTL1
|
[NCBI]
|
1.44414e-05
|
|
|
EVC
|
[NCBI]
|
1.44414e-05
|
|
|
HLA-DRA
|
[NCBI]
|
1.43446e-05
|
|
|
fabry disease
|
[NCBI]
|
1.42128e-05
|
|
|
usher syndrome, type i
|
[NCBI]
|
1.38683e-05
|
|
|
HSAS
|
[NCBI]
|
1.38683e-05
|
|
|
SPDA1
|
[NCBI]
|
1.38683e-05
|
|
|
FBXW4
|
[NCBI]
|
1.37748e-05
|
|
|
IL5RA
|
[NCBI]
|
1.37748e-05
|
|
|
FIP1L1
|
[NCBI]
|
1.37748e-05
|
|
|
CTRB1
|
[NCBI]
|
1.37748e-05
|
|
|
CSNK2A2
|
[NCBI]
|
1.37748e-05
|
|
|
NFIA
|
[NCBI]
|
1.37748e-05
|
|
|
ACTN4
|
[NCBI]
|
1.37748e-05
|
|
|
PCDH11Y
|
[NCBI]
|
1.37748e-05
|
|
|
DBY
|
[NCBI]
|
1.37748e-05
|
|
|
CAMK4
|
[NCBI]
|
1.37748e-05
|
|
|
PRB2
|
[NCBI]
|
1.37748e-05
|
|
|
IL1R1
|
[NCBI]
|
1.37748e-05
|
|
|
PCK1
|
[NCBI]
|
1.37748e-05
|
|
|
ATP2C1
|
[NCBI]
|
1.37748e-05
|
|
|
CA3
|
[NCBI]
|
1.37748e-05
|
|
|
PCDH11X
|
[NCBI]
|
1.37748e-05
|
|
|
RENBP
|
[NCBI]
|
1.37748e-05
|
|
|
KCNQ3
|
[NCBI]
|
1.37748e-05
|
|
|
IL1RAPL1
|
[NCBI]
|
1.37748e-05
|
|
|
TAP2
|
[NCBI]
|
1.37748e-05
|
|
|
GNRH1
|
[NCBI]
|
1.37591e-05
|
|
|
PG
|
[NCBI]
|
1.37566e-05
|
|
|
WT1
|
[NCBI]
|
1.36602e-05
|
|
|
KAL1
|
[NCBI]
|
1.36456e-05
|
|
|
STGD1
|
[NCBI]
|
1.33217e-05
|
|
|
RP1
|
[NCBI]
|
1.33217e-05
|
|
|
alzheimer disease 3
|
[NCBI]
|
1.33217e-05
|
|
|
leiomyomatosis and renal cell cancer, hereditary
|
[NCBI]
|
1.33217e-05
|
|
|
ATRX
|
[NCBI]
|
1.33217e-05
|
|
|
SLC9A1
|
[NCBI]
|
1.29565e-05
|
|
|
RNU2
|
[NCBI]
|
1.29565e-05
|
|
|
PBX1
|
[NCBI]
|
1.29565e-05
|
|
|
BLVRA
|
[NCBI]
|
1.29565e-05
|
|
|
RLN1
|
[NCBI]
|
1.29565e-05
|
|
|
BECN1
|
[NCBI]
|
1.29565e-05
|
|
|
ISL1
|
[NCBI]
|
1.29565e-05
|
|
|
BCYRN1
|
[NCBI]
|
1.29565e-05
|
|
|
PTPRG
|
[NCBI]
|
1.29565e-05
|
|
|
COPS5
|
[NCBI]
|
1.29565e-05
|
|
|
TM4SF2
|
[NCBI]
|
1.29565e-05
|
|
|
CLDN14
|
[NCBI]
|
1.29565e-05
|
|
|
CHRNG
|
[NCBI]
|
1.29565e-05
|
|
|
EIF6
|
[NCBI]
|
1.29565e-05
|
|
|
INHBB
|
[NCBI]
|
1.29565e-05
|
|
|
glycogen storage disease vi
|
[NCBI]
|
1.29565e-05
|
|
|
BCL3
|
[NCBI]
|
1.29565e-05
|
|
|
MAPK8IP3
|
[NCBI]
|
1.29565e-05
|
|
|
OGT
|
[NCBI]
|
1.29565e-05
|
|
|
GRIA4
|
[NCBI]
|
1.29565e-05
|
|
|
POU3F1
|
[NCBI]
|
1.29565e-05
|
|
|
DKC
|
[NCBI]
|
1.27998e-05
|
|
|
STL1
|
[NCBI]
|
1.27998e-05
|
|
|
COL3A1
|
[NCBI]
|
1.27914e-05
|
|
|
COL1A1
|
[NCBI]
|
1.26448e-05
|
|
|
PI
|
[NCBI]
|
1.26208e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
1.24171e-05
|
|
|
LGMD2C
|
[NCBI]
|
1.2301e-05
|
|
|
CCKBR
|
[NCBI]
|
1.22454e-05
|
|
|
OPRD1
|
[NCBI]
|
1.22454e-05
|
|
|
VIL
|
[NCBI]
|
1.22454e-05
|
|
|
SACS
|
[NCBI]
|
1.22454e-05
|
|
|
OPHN1
|
[NCBI]
|
1.22454e-05
|
|
|
SLC2A8
|
[NCBI]
|
1.22454e-05
|
|
|
DR1
|
[NCBI]
|
1.22454e-05
|
|
|
PDZK1
|
[NCBI]
|
1.22454e-05
|
|
|
ARHGEF6
|
[NCBI]
|
1.22454e-05
|
|
|
ERCC4
|
[NCBI]
|
1.22454e-05
|
|
|
AK3
|
[NCBI]
|
1.22454e-05
|
|
|
DFNA5
|
[NCBI]
|
1.22454e-05
|
|
|
SFRS1
|
[NCBI]
|
1.22454e-05
|
|
|
PRH2
|
[NCBI]
|
1.22454e-05
|
|
|
TPR
|
[NCBI]
|
1.22454e-05
|
|
|
PEX5
|
[NCBI]
|
1.22454e-05
|
|
|
MTND1
|
[NCBI]
|
1.22016e-05
|
|
|
OPMD
|
[NCBI]
|
1.18735e-05
|
|
|
SGBS1
|
[NCBI]
|
1.18237e-05
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
1.18237e-05
|
|
|
cystinuria
|
[NCBI]
|
1.18237e-05
|
|
|
KIT
|
[NCBI]
|
1.16499e-05
|
|
|
SLC6A3
|
[NCBI]
|
1.16335e-05
|
|
|
CEBPE
|
[NCBI]
|
1.16176e-05
|
|
|
APBA1
|
[NCBI]
|
1.16176e-05
|
|
|
PTPRF
|
[NCBI]
|
1.16176e-05
|
|
|
IL9R
|
[NCBI]
|
1.16176e-05
|
|
|
ZFPM2
|
[NCBI]
|
1.16176e-05
|
|
|
WHSC1
|
[NCBI]
|
1.16176e-05
|
|
|
LMBR1
|
[NCBI]
|
1.16176e-05
|
|
|
CD28
|
[NCBI]
|
1.16176e-05
|
|
|
MAP2K2
|
[NCBI]
|
1.16176e-05
|
|
|
APOA5
|
[NCBI]
|
1.16176e-05
|
|
|
TMSB4X
|
[NCBI]
|
1.16176e-05
|
|
|
MYOCD
|
[NCBI]
|
1.16176e-05
|
|
|
PHKA1
|
[NCBI]
|
1.16176e-05
|
|
|
TSPY
|
[NCBI]
|
1.16176e-05
|
|
|
RECQL4
|
[NCBI]
|
1.16176e-05
|
|
|
BBS4
|
[NCBI]
|
1.16176e-05
|
|
|
SCO2
|
[NCBI]
|
1.16176e-05
|
|
|
HBE1
|
[NCBI]
|
1.16176e-05
|
|
|
SOX4
|
[NCBI]
|
1.16176e-05
|
|
|
LITAF
|
[NCBI]
|
1.16176e-05
|
|
|
EYA4
|
[NCBI]
|
1.16176e-05
|
|
|
PABPN1
|
[NCBI]
|
1.16176e-05
|
|
|
IGKV
|
[NCBI]
|
1.16176e-05
|
|
|
CHEK1
|
[NCBI]
|
1.16176e-05
|
|
|
PARK2
|
[NCBI]
|
1.13666e-05
|
|
|
RPGR
|
[NCBI]
|
1.11325e-05
|
|
|
HTR1A
|
[NCBI]
|
1.10562e-05
|
|
|
RPA1
|
[NCBI]
|
1.10562e-05
|
|
|
GRIA3
|
[NCBI]
|
1.10562e-05
|
|
|
NPHP1
|
[NCBI]
|
1.10562e-05
|
|
|
FACL4
|
[NCBI]
|
1.10562e-05
|
|
|
PTPRO
|
[NCBI]
|
1.10562e-05
|
|
|
TLX1
|
[NCBI]
|
1.10562e-05
|
|
|
POT1
|
[NCBI]
|
1.10562e-05
|
|
|
CCNB1
|
[NCBI]
|
1.10562e-05
|
|
|
TBPL1
|
[NCBI]
|
1.10562e-05
|
|
|
HPR
|
[NCBI]
|
1.10562e-05
|
|
|
PRM1
|
[NCBI]
|
1.10562e-05
|
|
|
LIM2
|
[NCBI]
|
1.10562e-05
|
|
|
C1QA
|
[NCBI]
|
1.10562e-05
|
|
|
EPHA4
|
[NCBI]
|
1.10562e-05
|
|
|
HOXA13
|
[NCBI]
|
1.10562e-05
|
|
|
STXBP1
|
[NCBI]
|
1.10562e-05
|
|
|
MFGE8
|
[NCBI]
|
1.10562e-05
|
|
|
CML
|
[NCBI]
|
1.09286e-05
|
|
|
myoclonic dystonia
|
[NCBI]
|
1.09286e-05
|
|
|
SPG4
|
[NCBI]
|
1.09286e-05
|
|
|
CMH
|
[NCBI]
|
1.07245e-05
|
|
|
KRAS
|
[NCBI]
|
1.06459e-05
|
|
|
ADH3
|
[NCBI]
|
1.05491e-05
|
|
|
FTCD
|
[NCBI]
|
1.05491e-05
|
|
|
MYO15A
|
[NCBI]
|
1.05491e-05
|
|
|
GAD1
|
[NCBI]
|
1.05491e-05
|
|
|
KRT17
|
[NCBI]
|
1.05491e-05
|
|
|
BRIP1
|
[NCBI]
|
1.05491e-05
|
|
|
SEPT5
|
[NCBI]
|
1.05491e-05
|
|
|
MCPH1
|
[NCBI]
|
1.05491e-05
|
|
|
IGHMBP2
|
[NCBI]
|
1.05491e-05
|
|
|
MATN1
|
[NCBI]
|
1.05491e-05
|
|
|
FLCN
|
[NCBI]
|
1.05491e-05
|
|
|
RAB7
|
[NCBI]
|
1.05491e-05
|
|
|
SOST
|
[NCBI]
|
1.05491e-05
|
|
|
KCNQ4
|
[NCBI]
|
1.05491e-05
|
|
|
SMARCA4
|
[NCBI]
|
1.05491e-05
|
|
|
ZNF9
|
[NCBI]
|
1.05491e-05
|
|
|
MS4A2
|
[NCBI]
|
1.05491e-05
|
|
|
MERTK
|
[NCBI]
|
1.05491e-05
|
|
|
TIMM8A
|
[NCBI]
|
1.05491e-05
|
|
|
HIGM1
|
[NCBI]
|
1.05083e-05
|
|
|
FCAS
|
[NCBI]
|
1.05083e-05
|
|
|
CDPX2
|
[NCBI]
|
1.05083e-05
|
|
|
phenylketonuria
|
[NCBI]
|
1.0396e-05
|
|
|
BWS
|
[NCBI]
|
1.03564e-05
|
|
|
PCNA
|
[NCBI]
|
1.02896e-05
|
|
|
DNTT
|
[NCBI]
|
1.01872e-05
|
|
|
PLG
|
[NCBI]
|
1.01201e-05
|
|
|
kartagener syndrome
|
[NCBI]
|
1.0105e-05
|
|
|
RBPSUH
|
[NCBI]
|
1.00873e-05
|
|
|
IL8RB
|
[NCBI]
|
1.00873e-05
|
|
|
SULT1A1
|
[NCBI]
|
1.00873e-05
|
|
|
AEBP1
|
[NCBI]
|
1.00873e-05
|
|
|
KRT8
|
[NCBI]
|
1.00873e-05
|
|
|
SPINK5
|
[NCBI]
|
1.00873e-05
|
|
|
DYRK1A
|
[NCBI]
|
1.00873e-05
|
|
|
KRT15
|
[NCBI]
|
1.00873e-05
|
|
|
PAK3
|
[NCBI]
|
1.00873e-05
|
|
|
ZFY
|
[NCBI]
|
1.00873e-05
|
|
|
SILV
|
[NCBI]
|
1.00873e-05
|
|
|
SELL
|
[NCBI]
|
1.00873e-05
|
|
|
ART4
|
[NCBI]
|
1.00873e-05
|
|
|
ERBB4
|
[NCBI]
|
1.00873e-05
|
|
|
MAD2L1
|
[NCBI]
|
1.00873e-05
|
|
|
TREX1
|
[NCBI]
|
1.00873e-05
|
|
|
NDRG1
|
[NCBI]
|
1.00873e-05
|
|
|
ICAM5
|
[NCBI]
|
1.00873e-05
|
|
|
IP
|
[NCBI]
|
1.00811e-05
|
|
|
GPT
|
[NCBI]
|
9.75388e-06
|
|
|
CDC2
|
[NCBI]
|
9.75388e-06
|
|
|
LFS1
|
[NCBI]
|
9.71749e-06
|
|
|
OCA1A
|
[NCBI]
|
9.71749e-06
|
|
|
lactase persistence
|
[NCBI]
|
9.71749e-06
|
|
|
RANBP2
|
[NCBI]
|
9.66375e-06
|
|
|
MPI
|
[NCBI]
|
9.66375e-06
|
|
|
MCOLN1
|
[NCBI]
|
9.66375e-06
|
|
|
FLI1
|
[NCBI]
|
9.66375e-06
|
|
|
ODC1
|
[NCBI]
|
9.66375e-06
|
|
|
SKI
|
[NCBI]
|
9.66375e-06
|
|
|
CCS
|
[NCBI]
|
9.66375e-06
|
|
|
PEPA
|
[NCBI]
|
9.66375e-06
|
|
|
PXMP3
|
[NCBI]
|
9.66375e-06
|
|
|
NQO1
|
[NCBI]
|
9.66375e-06
|
|
|
NOV
|
[NCBI]
|
9.66375e-06
|
|
|
ADH1
|
[NCBI]
|
9.66375e-06
|
|
|
FCGR2A
|
[NCBI]
|
9.66375e-06
|
|
|
XG
|
[NCBI]
|
9.66375e-06
|
|
|
PDE4D
|
[NCBI]
|
9.66375e-06
|
|
|
COMT
|
[NCBI]
|
9.44128e-06
|
|
|
HYPP
|
[NCBI]
|
9.34507e-06
|
|
|
CTNS
|
[NCBI]
|
9.34507e-06
|
|
|
TECTA
|
[NCBI]
|
9.27298e-06
|
|
|
GAP43
|
[NCBI]
|
9.27298e-06
|
|
|
FUT1
|
[NCBI]
|
9.27298e-06
|
|
|
LMO2
|
[NCBI]
|
9.27298e-06
|
|
|
PFKL
|
[NCBI]
|
9.27298e-06
|
|
|
DCTN1
|
[NCBI]
|
9.27298e-06
|
|
|
ACO1
|
[NCBI]
|
9.27298e-06
|
|
|
PRX
|
[NCBI]
|
9.27298e-06
|
|
|
CACNA1F
|
[NCBI]
|
9.27298e-06
|
|
|
MTMR2
|
[NCBI]
|
9.27298e-06
|
|
|
DRD4
|
[NCBI]
|
9.08224e-06
|
|
|
PPARA
|
[NCBI]
|
9.02222e-06
|
|
|
TRPS2
|
[NCBI]
|
8.9869e-06
|
|
|
HHF1
|
[NCBI]
|
8.9869e-06
|
|
|
BTHS
|
[NCBI]
|
8.9869e-06
|
|
|
THRB
|
[NCBI]
|
8.95487e-06
|
|
|
TBX21
|
[NCBI]
|
8.9106e-06
|
|
|
POMT1
|
[NCBI]
|
8.9106e-06
|
|
|
THBS1
|
[NCBI]
|
8.9106e-06
|
|
|
OTOF
|
[NCBI]
|
8.9106e-06
|
|
|
SOCS2
|
[NCBI]
|
8.9106e-06
|
|
|
ENAM
|
[NCBI]
|
8.9106e-06
|
|
|
TUBB
|
[NCBI]
|
8.9106e-06
|
|
|
APOA4
|
[NCBI]
|
8.9106e-06
|
|
|
PFC
|
[NCBI]
|
8.9106e-06
|
|
|
BMPR2
|
[NCBI]
|
8.9106e-06
|
|
|
ID1
|
[NCBI]
|
8.9106e-06
|
|
|
CTNS
|
[NCBI]
|
8.9106e-06
|
|
|
ME2
|
[NCBI]
|
8.9106e-06
|
|
|
TNFRSF25
|
[NCBI]
|
8.9106e-06
|
|
|
HOXA7
|
[NCBI]
|
8.9106e-06
|
|
|
RPS3
|
[NCBI]
|
8.9106e-06
|
|
|
C4BPA
|
[NCBI]
|
8.9106e-06
|
|
|
CMM
|
[NCBI]
|
8.68967e-06
|
|
|
XIST
|
[NCBI]
|
8.58558e-06
|
|
|
MLH1
|
[NCBI]
|
8.58558e-06
|
|
|
BMPR1A
|
[NCBI]
|
8.57307e-06
|
|
|
MC3R
|
[NCBI]
|
8.57307e-06
|
|
|
CRYBB2
|
[NCBI]
|
8.57307e-06
|
|
|
ATF1
|
[NCBI]
|
8.57307e-06
|
|
|
CNR1
|
[NCBI]
|
8.57307e-06
|
|
|
RAPSN
|
[NCBI]
|
8.57307e-06
|
|
|
ALOX5
|
[NCBI]
|
8.57307e-06
|
|
|
XCL1
|
[NCBI]
|
8.57307e-06
|
|
|
BL
|
[NCBI]
|
8.47176e-06
|
|
|
APOA1
|
[NCBI]
|
8.46657e-06
|
|
|
UGB
|
[NCBI]
|
8.34951e-06
|
|
|
BMD
|
[NCBI]
|
8.31048e-06
|
|
|
IGER
|
[NCBI]
|
8.31048e-06
|
|
|
KCNQ1OT1
|
[NCBI]
|
8.25745e-06
|
|
|
MAN2B1
|
[NCBI]
|
8.25745e-06
|
|
|
MYO6
|
[NCBI]
|
8.25745e-06
|
|
|
CRYBA1
|
[NCBI]
|
8.25745e-06
|
|
|
KEL
|
[NCBI]
|
8.25745e-06
|
|
|
IL7R
|
[NCBI]
|
8.25745e-06
|
|
|
TAZ
|
[NCBI]
|
8.25745e-06
|
|
|
SCNN1B
|
[NCBI]
|
8.25745e-06
|
|
|
GCG
|
[NCBI]
|
8.25745e-06
|
|
|
NSD1
|
[NCBI]
|
8.25745e-06
|
|
|
KSS
|
[NCBI]
|
8.15884e-06
|
|
|
HSAN3
|
[NCBI]
|
7.99091e-06
|
|
|
HAE
|
[NCBI]
|
7.99091e-06
|
|
|
EXT2
|
[NCBI]
|
7.96131e-06
|
|
|
F2RL1
|
[NCBI]
|
7.96131e-06
|
|
|
SURF1
|
[NCBI]
|
7.96131e-06
|
|
|
NEFL
|
[NCBI]
|
7.96131e-06
|
|
|
TAL1
|
[NCBI]
|
7.96131e-06
|
|
|
SPG7
|
[NCBI]
|
7.96131e-06
|
|
|
TGM2
|
[NCBI]
|
7.96131e-06
|
|
|
ACY1
|
[NCBI]
|
7.96131e-06
|
|
|
USH1C
|
[NCBI]
|
7.96131e-06
|
|
|
TCF3
|
[NCBI]
|
7.96131e-06
|
|
|
TSHB
|
[NCBI]
|
7.96131e-06
|
|
|
TS
|
[NCBI]
|
7.94882e-06
|
|
|
BSG
|
[NCBI]
|
7.8999e-06
|
|
|
XPA
|
[NCBI]
|
7.68299e-06
|
|
|
FOXL2
|
[NCBI]
|
7.68259e-06
|
|
|
PQBP1
|
[NCBI]
|
7.68259e-06
|
|
|
XRCC9
|
[NCBI]
|
7.68259e-06
|
|
|
FRAXE
|
[NCBI]
|
7.68259e-06
|
|
|
LMX1B
|
[NCBI]
|
7.68259e-06
|
|
|
IRDN
|
[NCBI]
|
7.68259e-06
|
|
|
GUCY2D
|
[NCBI]
|
7.68259e-06
|
|
|
COL11A2
|
[NCBI]
|
7.68259e-06
|
|
|
CVID
|
[NCBI]
|
7.64377e-06
|
|
|
AQP1
|
[NCBI]
|
7.581e-06
|
|
|
PHOX2B
|
[NCBI]
|
7.41954e-06
|
|
|
IGHV
|
[NCBI]
|
7.41954e-06
|
|
|
AMELX
|
[NCBI]
|
7.41954e-06
|
|
|
C9
|
[NCBI]
|
7.41954e-06
|
|
|
LAD
|
[NCBI]
|
7.38616e-06
|
|
|
LCT
|
[NCBI]
|
7.3765e-06
|
|
|
XK
|
[NCBI]
|
7.17068e-06
|
|
|
HR
|
[NCBI]
|
7.17068e-06
|
|
|
GJB6
|
[NCBI]
|
7.17068e-06
|
|
|
DICER1
|
[NCBI]
|
7.17068e-06
|
|
|
CLN3
|
[NCBI]
|
7.17068e-06
|
|
|
BCNS
|
[NCBI]
|
7.15228e-06
|
|
|
sotos syndrome
|
[NCBI]
|
7.09993e-06
|
|
|
SCS
|
[NCBI]
|
7.09993e-06
|
|
|
TNFRSF1A
|
[NCBI]
|
6.9857e-06
|
|
|
SOD2
|
[NCBI]
|
6.97052e-06
|
|
|
GHSR
|
[NCBI]
|
6.93471e-06
|
|
|
ERCC1
|
[NCBI]
|
6.93471e-06
|
|
|
MPL
|
[NCBI]
|
6.93471e-06
|
|
|
complement component 8 deficiency, type i
|
[NCBI]
|
6.93471e-06
|
|
|
LRE1
|
[NCBI]
|
6.93471e-06
|
|
|
OR1D2
|
[NCBI]
|
6.93471e-06
|
|
|
AACT
|
[NCBI]
|
6.7105e-06
|
|
|
NRP1
|
[NCBI]
|
6.7105e-06
|
|
|
RHD
|
[NCBI]
|
6.7105e-06
|
|
|
WFS1
|
[NCBI]
|
6.7105e-06
|
|
|
HFE
|
[NCBI]
|
6.5993e-06
|
|
|
NPS
|
[NCBI]
|
6.55739e-06
|
|
|
neuroblastoma
|
[NCBI]
|
6.55739e-06
|
|
|
PMM2
|
[NCBI]
|
6.49709e-06
|
|
|
MFN2
|
[NCBI]
|
6.49709e-06
|
|
|
COL4A1
|
[NCBI]
|
6.49709e-06
|
|
|
CDH23
|
[NCBI]
|
6.49709e-06
|
|
|
CRYAA
|
[NCBI]
|
6.49709e-06
|
|
|
MTND3
|
[NCBI]
|
6.49709e-06
|
|
|
CASP1
|
[NCBI]
|
6.49709e-06
|
|
|
PYY
|
[NCBI]
|
6.34138e-06
|
|
|
TF
|
[NCBI]
|
6.30685e-06
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
6.30024e-06
|
|
|
LNS
|
[NCBI]
|
6.30024e-06
|
|
|
MYO5A
|
[NCBI]
|
6.2936e-06
|
|
|
LRP5
|
[NCBI]
|
6.2936e-06
|
|
|
EGR2
|
[NCBI]
|
6.2936e-06
|
|
|
SLC3A1
|
[NCBI]
|
6.2936e-06
|
|
|
CD59
|
[NCBI]
|
6.09927e-06
|
|
|
PAX2
|
[NCBI]
|
6.09927e-06
|
|
|
PNKP
|
[NCBI]
|
6.09927e-06
|
|
|
IL2RG
|
[NCBI]
|
6.09927e-06
|
|
|
CDKN1C
|
[NCBI]
|
6.09927e-06
|
|
|
PMS2
|
[NCBI]
|
6.09927e-06
|
|
|
SCN1A
|
[NCBI]
|
6.09927e-06
|
|
|
MAPK7
|
[NCBI]
|
6.09927e-06
|
|
|
pta deficiency
|
[NCBI]
|
6.09927e-06
|
|
|
DAG1
|
[NCBI]
|
6.09927e-06
|
|
|
obesity
|
[NCBI]
|
6.05197e-06
|
|
|
GRA
|
[NCBI]
|
6.05197e-06
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
6.04214e-06
|
|
|
CDC42
|
[NCBI]
|
5.91342e-06
|
|
|
AHSG
|
[NCBI]
|
5.91342e-06
|
|
|
CRYAB
|
[NCBI]
|
5.91342e-06
|
|
|
GSTM1
|
[NCBI]
|
5.91342e-06
|
|
|
EYA1
|
[NCBI]
|
5.91342e-06
|
|
|
ADH2
|
[NCBI]
|
5.91342e-06
|
|
|
CCM
|
[NCBI]
|
5.81222e-06
|
|
|
AMC
|
[NCBI]
|
5.81222e-06
|
|
|
GNAS
|
[NCBI]
|
5.78367e-06
|
|
|
SLC17A7
|
[NCBI]
|
5.73545e-06
|
|
|
GJA8
|
[NCBI]
|
5.73545e-06
|
|
|
TNNT2
|
[NCBI]
|
5.73545e-06
|
|
|
GUSB
|
[NCBI]
|
5.70647e-06
|
|
|
WS1
|
[NCBI]
|
5.58065e-06
|
|
|
IPF1
|
[NCBI]
|
5.56481e-06
|
|
|
SLC22A6
|
[NCBI]
|
5.56481e-06
|
|
|
COL17A1
|
[NCBI]
|
5.56481e-06
|
|
|
ARX
|
[NCBI]
|
5.56481e-06
|
|
|
HLA-DQA1
|
[NCBI]
|
5.56481e-06
|
|
|
SMPD1
|
[NCBI]
|
5.56481e-06
|
|
|
PMD
|
[NCBI]
|
5.55273e-06
|
|
|
CYP1A1
|
[NCBI]
|
5.49208e-06
|
|
|
CP
|
[NCBI]
|
5.42485e-06
|
|
|
TNFSF8
|
[NCBI]
|
5.40101e-06
|
|
|
GSTP1
|
[NCBI]
|
5.40101e-06
|
|
|
ALDH1A2
|
[NCBI]
|
5.40101e-06
|
|
|
PTX3
|
[NCBI]
|
5.40101e-06
|
|
|
IFNA1
|
[NCBI]
|
5.26449e-06
|
|
|
IL1B
|
[NCBI]
|
5.24361e-06
|
|
|
GRIN1
|
[NCBI]
|
5.24361e-06
|
|
|
CSTB
|
[NCBI]
|
5.24361e-06
|
|
|
IRS2
|
[NCBI]
|
5.24361e-06
|
|
|
TWIST1
|
[NCBI]
|
5.24361e-06
|
|
|
E2F1
|
[NCBI]
|
5.24361e-06
|
|
|
MTM1
|
[NCBI]
|
5.1408e-06
|
|
|
FTL
|
[NCBI]
|
5.09221e-06
|
|
|
IGF1R
|
[NCBI]
|
5.09221e-06
|
|
|
GLI3
|
[NCBI]
|
5.09221e-06
|
|
|
ALDH3A2
|
[NCBI]
|
5.09221e-06
|
|
|
COL6A1
|
[NCBI]
|
5.09221e-06
|
|
|
DCN
|
[NCBI]
|
5.09221e-06
|
|
|
SMAD4
|
[NCBI]
|
5.09221e-06
|
|
|
MFS
|
[NCBI]
|
4.99947e-06
|
|
|
INS
|
[NCBI]
|
4.96832e-06
|
|
|
FMR1
|
[NCBI]
|
4.91917e-06
|
|
|
SAA1
|
[NCBI]
|
4.80599e-06
|
|
|
IL5
|
[NCBI]
|
4.80599e-06
|
|
|
POU1F1
|
[NCBI]
|
4.80599e-06
|
|
|
ADORA3
|
[NCBI]
|
4.80599e-06
|
|
|
SLS
|
[NCBI]
|
4.73006e-06
|
|
|
GLB1
|
[NCBI]
|
4.67054e-06
|
|
|
ERCC5
|
[NCBI]
|
4.67054e-06
|
|
|
PEPD
|
[NCBI]
|
4.67054e-06
|
|
|
SPG4
|
[NCBI]
|
4.67054e-06
|
|
|
ATM
|
[NCBI]
|
4.66347e-06
|
|
|
PSIP1
|
[NCBI]
|
4.53981e-06
|
|
|
PIGA
|
[NCBI]
|
4.53981e-06
|
|
|
SLAMF1
|
[NCBI]
|
4.53981e-06
|
|
|
ICAM1
|
[NCBI]
|
4.53981e-06
|
|
|
GHRL
|
[NCBI]
|
4.53981e-06
|
|
|
OA1
|
[NCBI]
|
4.53981e-06
|
|
|
aspartylglucosaminuria
|
[NCBI]
|
4.53981e-06
|
|
|
ACE
|
[NCBI]
|
4.42696e-06
|
|
|
AVPR2
|
[NCBI]
|
4.41354e-06
|
|
|
RPS6KA3
|
[NCBI]
|
4.41354e-06
|
|
|
NTRK2
|
[NCBI]
|
4.41354e-06
|
|
|
PRPH2
|
[NCBI]
|
4.41354e-06
|
|
|
GDNF
|
[NCBI]
|
4.37145e-06
|
|
|
LQT1
|
[NCBI]
|
4.34632e-06
|
|
|
PF4
|
[NCBI]
|
4.31692e-06
|
|
|
ESD
|
[NCBI]
|
4.29945e-06
|
|
|
XPA
|
[NCBI]
|
4.29151e-06
|
|
|
ESR2
|
[NCBI]
|
4.29151e-06
|
|
|
ALDH2
|
[NCBI]
|
4.29151e-06
|
|
|
APOC2
|
[NCBI]
|
4.29151e-06
|
|
|
FN1
|
[NCBI]
|
4.29151e-06
|
|
|
SLC26A4
|
[NCBI]
|
4.29151e-06
|
|
|
GRIA2
|
[NCBI]
|
4.1735e-06
|
|
|
PDE6B
|
[NCBI]
|
4.1735e-06
|
|
|
CHEK2
|
[NCBI]
|
4.1735e-06
|
|
|
HOS
|
[NCBI]
|
4.16399e-06
|
|
|
XDH
|
[NCBI]
|
4.07613e-06
|
|
|
SLC1A2
|
[NCBI]
|
4.0593e-06
|
|
|
NOD2
|
[NCBI]
|
4.0593e-06
|
|
|
C4B
|
[NCBI]
|
4.0593e-06
|
|
|
DES
|
[NCBI]
|
3.94873e-06
|
|
|
SMN2
|
[NCBI]
|
3.94873e-06
|
|
|
ATP7B
|
[NCBI]
|
3.94873e-06
|
|
|
EDN1
|
[NCBI]
|
3.94873e-06
|
|
|
MB
|
[NCBI]
|
3.88367e-06
|
|
|
PDHA1
|
[NCBI]
|
3.84162e-06
|
|
|
MST1
|
[NCBI]
|
3.84162e-06
|
|
|
CES
|
[NCBI]
|
3.81731e-06
|
|
|
MBP
|
[NCBI]
|
3.74497e-06
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
3.7378e-06
|
|
|
SOCS1
|
[NCBI]
|
3.63713e-06
|
|
|
BRAF
|
[NCBI]
|
3.63713e-06
|
|
|
GLA
|
[NCBI]
|
3.63713e-06
|
|
|
LPA
|
[NCBI]
|
3.63713e-06
|
|
|
GRIA1
|
[NCBI]
|
3.63713e-06
|
|
|
CYP17A1
|
[NCBI]
|
3.53946e-06
|
|
|
SVAS
|
[NCBI]
|
3.49329e-06
|
|
|
DAZ
|
[NCBI]
|
3.44467e-06
|
|
|
GSR
|
[NCBI]
|
3.44467e-06
|
|
|
ZNF145
|
[NCBI]
|
3.44467e-06
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
3.33931e-06
|
|
|
ABCA1
|
[NCBI]
|
3.26322e-06
|
|
|
DMPK
|
[NCBI]
|
3.26322e-06
|
|
|
DCT
|
[NCBI]
|
3.26322e-06
|
|
|
ERBB2
|
[NCBI]
|
3.26322e-06
|
|
|
IFNG
|
[NCBI]
|
3.26322e-06
|
|
|
LPI
|
[NCBI]
|
3.19048e-06
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
3.19048e-06
|
|
|
GC
|
[NCBI]
|
3.17211e-06
|
|
|
WAS
|
[NCBI]
|
3.09191e-06
|
|
|
DHFR
|
[NCBI]
|
3.08062e-06
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
3.04661e-06
|
|
|
NP
|
[NCBI]
|
3.0098e-06
|
|
|
CACNA1A
|
[NCBI]
|
3.0098e-06
|
|
|
TBG
|
[NCBI]
|
3.0098e-06
|
|
|
HBA1
|
[NCBI]
|
2.95099e-06
|
|
|
MAP1B
|
[NCBI]
|
2.92994e-06
|
|
|
DAO
|
[NCBI]
|
2.92994e-06
|
|
|
FH
|
[NCBI]
|
2.85223e-06
|
|
|
UNG
|
[NCBI]
|
2.7766e-06
|
|
|
AGT
|
[NCBI]
|
2.7766e-06
|
|
|
menkes disease
|
[NCBI]
|
2.77318e-06
|
|
|
CPI
|
[NCBI]
|
2.75019e-06
|
|
|
TP53
|
[NCBI]
|
2.74168e-06
|
|
|
ITGB2
|
[NCBI]
|
2.70298e-06
|
|
|
ABL1
|
[NCBI]
|
2.70298e-06
|
|
|
AVSD
|
[NCBI]
|
2.64334e-06
|
|
|
ALS1
|
[NCBI]
|
2.64334e-06
|
|
|
MSH2
|
[NCBI]
|
2.63129e-06
|
|
|
SLC18A2
|
[NCBI]
|
2.63129e-06
|
|
|
MYH7
|
[NCBI]
|
2.63129e-06
|
|
|
A2M
|
[NCBI]
|
2.56146e-06
|
|
|
DFFB
|
[NCBI]
|
2.49344e-06
|
|
|
PSACH
|
[NCBI]
|
2.39673e-06
|
|
|
G6PD
|
[NCBI]
|
2.37454e-06
|
|
|
CDH1
|
[NCBI]
|
2.29956e-06
|
|
|
PGK1
|
[NCBI]
|
2.29956e-06
|
|
|
alopecia, androgenetic
|
[NCBI]
|
2.27971e-06
|
|
|
OSM
|
[NCBI]
|
2.24437e-06
|
|
|
MTND4
|
[NCBI]
|
2.23816e-06
|
|
|
AQP4
|
[NCBI]
|
2.23816e-06
|
|
|
HRAS
|
[NCBI]
|
2.23816e-06
|
|
|
STAT3
|
[NCBI]
|
2.20764e-06
|
|
|
NF2
|
[NCBI]
|
2.17827e-06
|
|
|
lynch syndrome i
|
[NCBI]
|
2.16673e-06
|
|
|
MAFD1
|
[NCBI]
|
2.07396e-06
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
2.05767e-06
|
|
|
JAK3
|
[NCBI]
|
2.0073e-06
|
|
|
ELN
|
[NCBI]
|
2.0073e-06
|
|
|
NOTCH1
|
[NCBI]
|
1.95305e-06
|
|
|
CD36
|
[NCBI]
|
1.95305e-06
|
|
|
CCD
|
[NCBI]
|
1.95242e-06
|
|
|
CTNNB1
|
[NCBI]
|
1.84844e-06
|
|
|
APOD
|
[NCBI]
|
1.79801e-06
|
|
|
DSPP
|
[NCBI]
|
1.79801e-06
|
|
|
ANG
|
[NCBI]
|
1.74876e-06
|
|
|
AQP2
|
[NCBI]
|
1.74876e-06
|
|
|
CCR5
|
[NCBI]
|
1.74876e-06
|
|
|
UBTF
|
[NCBI]
|
1.70069e-06
|
|
|
MC4R
|
[NCBI]
|
1.65374e-06
|
|
|
LOX
|
[NCBI]
|
1.6079e-06
|
|
|
POMC
|
[NCBI]
|
1.60144e-06
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
1.56757e-06
|
|
|
SLC4A1
|
[NCBI]
|
1.56313e-06
|
|
|
SHH
|
[NCBI]
|
1.5399e-06
|
|
|
IL2
|
[NCBI]
|
1.52784e-06
|
|
|
ARSA
|
[NCBI]
|
1.5194e-06
|
|
|
leber optic atrophy
|
[NCBI]
|
1.48553e-06
|
|
|
CNTF
|
[NCBI]
|
1.4351e-06
|
|
|
BMP2
|
[NCBI]
|
1.39422e-06
|
|
|
BCHE
|
[NCBI]
|
1.30616e-06
|
|
|
MTHFR
|
[NCBI]
|
1.20412e-06
|
|
|
PJS
|
[NCBI]
|
1.08017e-06
|
|
|
COL1A2
|
[NCBI]
|
9.42424e-07
|
|
|
SMN1
|
[NCBI]
|
9.1301e-07
|
|
|
COL2A1
|
[NCBI]
|
9.1301e-07
|
|
|
MPZ
|
[NCBI]
|
8.5621e-07
|
|
|
GCK
|
[NCBI]
|
8.5621e-07
|
|
|
AMH
|
[NCBI]
|
7.8915e-07
|
|
|
PDCD8
|
[NCBI]
|
7.50296e-07
|
|
|
ADA
|
[NCBI]
|
7.44016e-07
|
|
|
CDK5
|
[NCBI]
|
6.38103e-07
|
|
|
FGFR3
|
[NCBI]
|
6.38103e-07
|
|
|
SRY
|
[NCBI]
|
6.31442e-07
|
|
|
ALB
|
[NCBI]
|
6.21174e-07
|
|
|
SRF
|
[NCBI]
|
5.62308e-07
|
|
|
DRPLA
|
[NCBI]
|
5.59267e-07
|
|
|
CPB2
|
[NCBI]
|
5.46208e-07
|
|
|
MYOC
|
[NCBI]
|
5.26188e-07
|
|
|
AKR1B1
|
[NCBI]
|
4.88363e-07
|
|
|
NRG1
|
[NCBI]
|
4.87627e-07
|
|
|
SDC2
|
[NCBI]
|
4.34923e-07
|
|
|
MAOA
|
[NCBI]
|
4.33355e-07
|
|
|
PLAUR
|
[NCBI]
|
3.99457e-07
|
|
|
ABCC1
|
[NCBI]
|
3.98336e-07
|
|
|
DBA
|
[NCBI]
|
3.902e-07
|
|
|
TLR9
|
[NCBI]
|
3.36866e-07
|
|
|
WAS
|
[NCBI]
|
3.24353e-07
|
|
|
APOB
|
[NCBI]
|
3.18225e-07
|
|
|
PPIA
|
[NCBI]
|
3.08057e-07
|
|
|
GJB1
|
[NCBI]
|
2.94252e-07
|
|
|
SOD1
|
[NCBI]
|
2.61657e-07
|
|
|
PTN
|
[NCBI]
|
2.55151e-07
|
|
|
MAPT
|
[NCBI]
|
2.55151e-07
|
|
|
SCZD
|
[NCBI]
|
2.53564e-07
|
|
|
CFTR
|
[NCBI]
|
2.25318e-07
|
|
|
KCNH2
|
[NCBI]
|
2.22335e-07
|
|
|
von willebrand disease
|
[NCBI]
|
2.19398e-07
|
|
|
HBA2
|
[NCBI]
|
1.8684e-07
|
|
|
PRNP
|
[NCBI]
|
1.55668e-07
|
|
|
INSR
|
[NCBI]
|
1.39294e-07
|
|
|
KDR
|
[NCBI]
|
1.14582e-07
|
|
|
TTR
|
[NCBI]
|
1.14445e-07
|
|
|
TBP
|
[NCBI]
|
9.25847e-08
|
|
|
CBX5
|
[NCBI]
|
7.93722e-08
|
|
|
EPOR
|
[NCBI]
|
7.31642e-08
|
|
|
HSCR1
|
[NCBI]
|
7.01584e-08
|
|
|
SST
|
[NCBI]
|
6.83365e-08
|
|
|
PEDF
|
[NCBI]
|
6.36584e-08
|
|
|
EV
|
[NCBI]
|
4.59532e-08
|
|
|
MS
|
[NCBI]
|
4.59532e-08
|
|
|
MECP2
|
[NCBI]
|
4.17903e-08
|
|
|
ABCB1
|
[NCBI]
|
4.17903e-08
|
|
|
FMF
|
[NCBI]
|
3.76445e-08
|
|
|
NGFR
|
[NCBI]
|
3.74731e-08
|
|
|
APC
|
[NCBI]
|
3.70918e-08
|
|
|
GJB2
|
[NCBI]
|
3.52313e-08
|
|
|
IHH
|
[NCBI]
|
2.8546e-08
|
|
|
CDK4
|
[NCBI]
|
1.97662e-08
|
|
|
PLK1
|
[NCBI]
|
1.4149e-08
|
|
|
TPO
|
[NCBI]
|
1.37703e-08
|
|
|
MJD
|
[NCBI]
|
7.88645e-09
|
|
|
APP
|
[NCBI]
|
5.36053e-09
|
|
|
DNMT1
|
[NCBI]
|
5.36053e-09
|
|
|
PLTP
|
[NCBI]
|
4.48475e-09
|
|
|
FGFR2
|
[NCBI]
|
3.21472e-09
|
|
|
BBS
|
[NCBI]
|
2.42063e-09
|
|
|
LCAT
|
[NCBI]
|
1.94863e-09
|
|